About this data
Pipeline and clinical trial information here comes primarily from ClinicalTrials.gov. A listing on ClinicalTrials.gov means a study has been registered — not that a treatment is proven safe, effective, or FDA-approved. Investigational treatments may never be approved. Who can join a trial is decided only by that trial's own study team.
COVID-19 vaccine
COVID-19 vaccine
- Company
- Swiss Federal Institute of Technology
- Mechanism
- Mechanism not yet reported
- Route
- Route not yet reported
- Recruiting trials
- 24 recruiting
Efficacy results: Not yet reported
24 recruiting studies currently listed on ClinicalTrials.gov.
Data source: ClinicalTrials.gov · trial data as of Nov 20, 2026
Find a Clinical Trial Near Me
See recruiting studies for COVID-19 vaccine and check eligibility with the study team.
Trial details
-
Recruiting NCT NCT03501576
Evaluation of Human Immune Responses Vaccination in Patients With Lymphoma
Emory University 200 participants Est. completion 2028-05-26 2 sitesOther conditions: Chronic Lymphocytic Leukemia, Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, Mantle Cell Lymphoma, Mature T-Cell and NK-Cell Non-Hodgkin LymphomaView official trial listing → -
Recruiting NCT NCT04706390
Comparison of the Immune Response to Natural COVID-19 Infection and Vaccination
University of Bergen 2500 participants Est. completion 2030-12-12 1 siteOther conditions: Covid19View official trial listing → -
Recruiting NCT NCT05046002
COVID-19 Vaccine-induced Inflammatory Heart Disease Prevalence Registry
Ottawa Heart Institute Research Corporation 400 participants Est. completion 2026-12-31 1 siteOther conditions: Myocarditis, PericarditisView official trial listing → -
Recruiting NCT NCT05197621
The Impact of COVID-19 on Maternal and Neonatal Outcomes
Johns Hopkins University 300 participants Est. completion 2028-05-05 1 siteOther conditions: COVID-19, Pregnancy; InfectionView official trial listing → -
Recruiting NCT NCT05415267
Immunosuppression and COVID-19 Boosters
Not yet reported Kirby Institute 320 participants Est. completion 2026-12-31 5 sitesOther conditions: COVID-19View official trial listing → -
Recruiting NCT NCT05571735
Immunogenicity of COVID-19 Vaccines in Tuberculosis Patients
University of Oxford 133 participants Est. completion 2026-06-30 1 siteOther conditions: Covid-19 Pandemics, TuberculosisView official trial listing → -
Recruiting NCT NCT05691790
Older People's Preventive Care Utilization
Not yet reported The University of Hong Kong 270 participants Est. completion 2025-05-31 1 siteOther conditions: Health CommunicationView official trial listing → -
Recruiting NCT NCT05973084
COVID-19 Transmission and Morbidity in Malawi
Boston University 1500 participants Est. completion 2028-03 2 sitesOther conditions: SARS CoV 2 Infection, SARS CoV 2 VaccinationView official trial listing → -
Recruiting NCT NCT06103123
MYocarditis and/or Pericarditis Following mRNA COVID-19 VACCination National Surveillance Study
Cardiology Research UBC 500 participants Est. completion 2027-04-23 1 siteOther conditions: Myocarditis, Myocarditis Acute, Pericarditis, Pericarditis AcuteView official trial listing → -
Recruiting NCT NCT06168032
COVID-19 Vaccine Effectiveness Against Recurrent Infection Among Lung Cancer Patients and Biomarker Research
Not yet reported Peking Union Medical College Hospital 1224 participants Est. completion 2026-12-08 1 siteOther conditions: COVID-19 Recurrent, Lung Cancer, Vaccination, Antibody, Chemotherapy, Immune Checkpoint InhibitorView official trial listing → -
Recruiting NCT NCT06355232
Covid-19 and Influenza Oral Vaccine Study
Not yet reported Vaxine Pty Ltd 100 participants Est. completion 2026-12-31 1 site Stand-aloneOther conditions: covid19 Infection, Influenza, HumanView official trial listing → -
Recruiting NCT NCT06381739
A Trial of a Next Generation COVID-19 Vaccine Delivered by Inhaled Aerosol
Not yet reported McMaster University 350 participants Est. completion 2027-01 2 sitesOther conditions: COVID-19 InfectionView official trial listing → -
Recruiting NCT NCT06441955
Covid-19 Long Haul Preventative and Health Promotion Care Clinical Trial Acceleration Program.
Not yet reported Well- Konnect Healthcare Services and Research Firm 100 participants Est. completion 2030-09-30 1 siteOther conditions: COVID-19, Long HaulView official trial listing → -
Recruiting NCT NCT06452654
Anti-viral Action Against Type 1 Diabetes Autoimmunity
Not yet reported Technical University of Munich 2252 participants Est. completion 2027-10 9 sitesOther conditions: Diabetes Mellitus, Type 1View official trial listing → -
Recruiting NCT NCT06635525
Impact Of Kidney Failure On The Regulation Of Humoral Response To Vaccination
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico 146 participants Est. completion 2026-07 3 sitesChronic kidney disease Other conditions: Vaccine ResponseView official trial listing → -
Recruiting NCT NCT06821126
Study Comparing Safety and Immunogenicity of Intranasal COVID-19 Vaccine and mRNA Booster in Healthy Adults
Not yet reported, Not yet reported ANRS, Emerging Infectious Diseases 238 participants Est. completion 2028-03 5 sitesOther conditions: HealthyView official trial listing → -
Recruiting NCT NCT06848309
Dissecting Human Immune Responses to Infection With Influenza or SARS-CoV-2
Washington University School of Medicine 300 participants Est. completion 2029-10 1 siteOther conditions: Influenza, SARS-CoV-2 (COVID-19) Infection, Immune Response of HostView official trial listing → -
Recruiting NCT NCT07287137
Comparative Immunogenicity of Respiratory Virus Vaccines (CIRV2) Study
Not yet reported Henry M. Jackson Foundation for the Advancement of Military Medicine 54 participants Est. completion 2027-09 1 siteOther conditions: COVID -19, COVID - 19, COVID 19, Influenza, Respiratory Virus, Respiratory Viruses, Respiratory Virus Infection, Respiratory Virus InfectionsView official trial listing → -
Recruiting NCT NCT07464314
A Study on the Safety and Immune Response of Investigational mRNA Seasonal Flu/COVID-19 Combination Vaccine in Adults
Not yet reported GlaxoSmithKline 225 participants Est. completion 2027-06-03 12 sitesOther conditions: Influenza, Human+COVID-19View official trial listing → -
Recruiting NCT NCT07597070
Universal Immunization to Fortify Immunotherapy Efficacy and Response
Not yet reported University of Florida 500 participants Est. completion 2035-03 1 siteOther conditions: Stage 4 NSCLCView official trial listing → -
Recruiting NCT NCT07605520
An Experimental Medicine Multicenter Trial to Evaluate the Safety and Immunogenicity of Experimental Versus Authorized SARS-CoV-2 Vaccine Candidates as a Booster Dose in Healthy Participants Previously Vaccinated With Authorized mRNA SARS-CoV-2 Vaccines.
Not yet reported ANRS, Emerging Infectious Diseases 48 participants Est. completion 2028-12 3 sitesOther conditions: Healthy AdultsView official trial listing → -
Recruiting NCT NCT07658196
TLR9 Immunotherapy for Peritoneal Carcinomatosis
Not yet reported Brown University 24 participants Est. completion 2030-07 1 siteOther conditions: Malignant Ascites, Colorectal Adenocarcinoma, Peritoneal (Metastatic) Cancer, Appendiceal AdenocarcinomaView official trial listing → -
Recruiting NCT NCT07730450
A Study to Learn About a COVID-19 Vaccine in Healthy Adults 18 Through 64 Years of Age
Not yet reported BioNTech SE 200 participants Est. completion 2027-08-20 5 sitesOther conditions: COVID-19 VaccinesView official trial listing → -
Recruiting NCT NCT07863635
A Study to Investigate the Immunogenicity and Safety of mRNA COVID-19 Variant-containing Formulations
Not yet reported ModernaTX, Inc. 600 participants Est. completion 2026-12-11 5 sitesOther conditions: SARS-CoV-2View official trial listing → -
Completed NCT NCT03092076
The Impact of Genotype on Pharmacokinetics and Antiplatelet Effects of Ticagrelor in Healthy Chinese
Not yet reported Guangdong Provincial People's Hospital 51 participants Est. completion 2016-06-16Other conditions: HealthyView official trial listing → -
Active, not recruiting NCT NCT03305341
Proof-of-Concept Clinical Pharmacology Trial for COVID-19 Antigen Presentation Therapeutic Biologic Mix
Not yet reported Han Xu, M.D., Ph.D., FAPCR, Sponsor-Investigator, IRB Chair 20 participants Est. completion 2026-12-28 1 site Stand-aloneOther conditions: Covid19View official trial listing → -
Completed NCT NCT04341389
A Phase II Clinical Trial to Evaluate the Recombinant Vaccine for COVID-19 (Adenovirus Vector)
Not yet reported Institute of Biotechnology, Academy of Military Medical Sciences, PLA of China 508 participants Est. completion 2020-12-31 1 siteOther conditions: COVID-19View official trial listing → -
Completed NCT NCT04368728
Study to Describe the Safety, Tolerability, Immunogenicity, and Efficacy of RNA Vaccine Candidates Against COVID-19 in Healthy Individuals
Not yet reported, Not yet reported BioNTech SE 46969 participants Est. completion 2023-02-10 175 sitesOther conditions: SARS-CoV-2 Infection, COVID-19View official trial listing → -
Completed NCT NCT04380701
A Trial Investigating the Safety and Effects of Four BNT162 Vaccines Against COVID-19 in Healthy and Immunocompromised Adults
Not yet reported, Not yet reported BioNTech SE 512 participants Est. completion 2022-04-13 5 sitesOther conditions: Infections, Respiratory, Virus Diseases, Infection Viral, Vaccine Adverse Reaction, RNA Virus Infections, Protection Against COVID-19 and Infections With SARS CoV 2View official trial listing → -
Completed NCT NCT04400838
Investigating a Vaccine Against COVID-19
Not yet reported, Not yet reported University of Oxford 10811 participants Est. completion 2025-02-05 20 sitesOther conditions: CoronavirusView official trial listing → -
Completed NCT NCT04405908
SCB-2019 as COVID-19 Vaccine
Not yet reported Clover Biopharmaceuticals AUS Pty 166 participants Est. completion 2021-12-08 1 siteOther conditions: COVID-19View official trial listing → -
Completed NCT NCT04436276
A Study of Ad26.COV2.S in Adults (COVID-19)
Not yet reported, Not yet reported Janssen Vaccines & Prevention B.V. 1085 participants Est. completion 2023-02-21 12 sitesOther conditions: Covid-19 PreventionView official trial listing → -
Status unknown NCT NCT04444674
COVID-19 Vaccine (ChAdOx1 nCoV-19) Trial in South African Adults With and Without HIV-infection
Not yet reported, Not yet reported University of Oxford 2130 participants Est. completion 2021-12 7 sitesOther conditions: CoronavirusView official trial listing → -
Completed NCT NCT04449276
A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of Vaccine CVnCoV in Healthy Adults for COVID-19
Not yet reported CureVac 280 participants Est. completion 2021-12-21 4 sitesOther conditions: Severe Acute Respiratory Syndrome, Coronavirus, SARS-CoV-2, COVID-19View official trial listing → -
Completed NCT NCT04460703
COVID-19 Vaccine Messaging, Part 1
Not yet reported Yale University 4000 participants Est. completion 2020-07-08 1 siteOther conditions: Vaccination, COVID-19View official trial listing → -
Completed NCT NCT04470609
Safety and Immunogenicity Study of an Inactivated SARS-CoV-2 Vaccine for Preventing Against COVID-19 in People Aged ⩾60 Years
Not yet reported, Not yet reported Institute of Medical Biology, Chinese Academy of Medical Sciences 471 participants Est. completion 2021-10-27 1 siteOther conditions: COVID-19View official trial listing → -
Completed NCT NCT04495933
A Study on the Safety, Tolerability and Immune Response of SARS-CoV-2 Sclamp (COVID-19) Vaccine in Healthy Adults
Not yet reported The University of Queensland 216 participants Est. completion 2024-04-30 1 siteOther conditions: SARS-CoV2, Covid19View official trial listing → -
Completed NCT NCT04497298
Clinical Trial to Evaluate the Safety and Immunogenicity of the COVID-19 Vaccine
Not yet reported Institut Pasteur 90 participants Est. completion 2021-05-12 2 sites Stand-aloneOther conditions: COVID-19View official trial listing → -
Completed NCT NCT04505722
A Study of Ad26.COV2.S for the Prevention of SARS-CoV-2-Mediated COVID-19 in Adult Participants
Not yet reported Janssen Vaccines & Prevention B.V. 44325 participants Est. completion 2023-03-31 225 sitesOther conditions: Participants With or Without Stable Co-morbidities Associated With Progression to Severe COVID-19 at Different Stages of the ProtocolView official trial listing → -
Completed NCT NCT04508075
Efficacy, Safety and Immunogenicity Study of SARS-CoV-2 Inactivated Vaccine
Not yet reported PT Bio Farma 1620 participants Est. completion 2021-08-31 1 siteOther conditions: SARS-CoV2 InfectionView official trial listing → -
Completed NCT NCT04530357
Reactogenicity, Safety and Immunogenicity of QazCovid-in® COVID-19 Vaccine
Not yet reported, Not yet reported Research Institute for Biological Safety Problems 244 participants Est. completion 2021-04-25 1 siteOther conditions: Covid19, SARS-CoV Infection, Vaccine Adverse ReactionView official trial listing → -
Completed NCT NCT04533399
A Study Looking at the Effectiveness and Safety of a COVID-19 Vaccine in South African Adults
Not yet reported Novavax 4422 participants Est. completion 2022-01-19 14 sitesOther conditions: SARS-CoV-2 Infection, COVID-19View official trial listing → -
Status unknown NCT NCT04536051
A Study of a Candidate COVID-19 Vaccine (COV003)
Not yet reported University of Oxford 10300 participants Est. completion 2021-09 6 sitesOther conditions: CoronavirusView official trial listing → -
Completed NCT NCT04537208
Study of Recombinant Protein Vaccine Formulations Against COVID-19 in Healthy Adults 18 Years of Age and Older
Not yet reported, Not yet reported Sanofi Pasteur, a Sanofi Company 441 participants Est. completion 2021-11-19 11 sitesOther conditions: COVID-19 (Healthy Volunteers)View official trial listing → -
Completed NCT NCT04551547
Safety and Immunogenicity Study of Inactivated Vaccine for Prevention of COVID-19
Not yet reported, Not yet reported Sinovac Research and Development Co., Ltd. 552 participants Est. completion 2023-02-08 1 siteOther conditions: COVID-19View official trial listing → -
Completed NCT NCT04560881
Clinical Trial to Evaluate the Efficacy, Immunogenicity and Safety of the Inactivated SARS-CoV-2 Vaccine (COVID-19)
Not yet reported Laboratorio Elea Phoenix S.A. 3000 participants Est. completion 2021-12-13 4 sitesOther conditions: COVID-19 Virus InfectionView official trial listing → -
Completed NCT NCT04582344
Clinical Trial For SARS-CoV-2 Vaccine (COVID-19)
Not yet reported Health Institutes of Turkey 10214 participants Est. completion 2022-07-27 25 sitesOther conditions: COVID-19View official trial listing → -
Completed NCT NCT04583995
A Study Looking at the Effectiveness, Immune Response, and Safety of a COVID-19 Vaccine in Adults in the United Kingdom
Not yet reported Novavax 15185 participants Est. completion 2022-03-29 33 sitesOther conditions: SARS-CoV-2 Infection, COVID-19View official trial listing → -
Status unknown NCT NCT04611243
Lung Function, Exercise Capacity, and Serology Responses in Patients With COVID-19
Chinese University of Hong Kong 700 participants Est. completion 2026-02-17 1 siteOther conditions: Lung Function, Exercise Capacity, Quality of Life, Covid19View official trial listing → -
Status unknown NCT NCT04636333
Phase I Trial of a Recombinant COVID-19 Vaccine (CHO Cell)
Not yet reported Jiangsu Province Centers for Disease Control and Prevention 216 participants Est. completion 2022-07-07 1 siteOther conditions: COVID-19View official trial listing → -
Active, not recruiting NCT NCT04636697
Study of a Recombinant Coronavirus-Like Particle COVID-19 Vaccine in Adults
Not yet reported, Not yet reported Medicago 30918 participants Est. completion 2022-04-30 91 sitesOther conditions: SARS-CoV-2 InfectionView official trial listing → -
Completed NCT NCT04651790
Efficacy, Safety, and Immunogenicity of Two Vaccination Schedules of an Inactivated Vaccine Against COVID-19 in Adults
Not yet reported Pontificia Universidad Catolica de Chile 2300 participants Est. completion 2022-11-01 1 siteOther conditions: Covid19, VaccinesView official trial listing → -
Status unknown NCT NCT04659239
The Efficacy, Safety and Immunogenicity Study of Inactivated SARS-CoV-2 Vaccine for Preventing Against COVID-19
Not yet reported Chinese Academy of Medical Sciences 34020 participants Est. completion 2022-07 2 sitesOther conditions: COVID-19View official trial listing → -
Withdrawn NCT NCT04665258
Male Reproduction COVID Sequelae Study (MARCOS).
University of Miami Est. completion 2023-11-28Other conditions: Infertility, MaleView official trial listing → -
Completed NCT NCT04684446
Study in Adults of AZD1222 and rAd26-S Administered as Heterologous Prime-Boost Regimen for the Prevention of COVID-19
Not yet reported, Not yet reported R-Pharm 100 participants Est. completion 2022-03-29 4 sitesOther conditions: COVID-19View official trial listing → -
Status unknown NCT NCT04686409
App-based Symptom Tracking After Corona Vaccination (CoCoV)
University of Ulm 500 participants Est. completion 2022-08-31 1 siteOther conditions: Adverse Events in COVID-19 VaccinationView official trial listing → -
Completed NCT NCT04690387
Dendritic Cell Vaccine, AV-COVID-19, to Prevent COVID-19 Infection
Not yet reported Aivita Biomedical, Inc. 27 participants Est. completion 2021-01-15 1 siteOther conditions: COVID-19View official trial listing → -
Completed NCT NCT04691908
Immunogenicity, Efficacy and Safety of QazCovid-in® COVID-19 Vaccine
Not yet reported Research Institute for Biological Safety Problems 3000 participants Est. completion 2021-07-11 1 siteOther conditions: Covid19, SARS-CoV Infection, Vaccine Adverse ReactionView official trial listing → -
Completed NCT NCT04691947
Safety and Immunogenicity of Two Different Strengths of the Inactivated COVID-19 Vaccine ERUCOV-VAC
Not yet reported Health Institutes of Turkey 44 participants Est. completion 2021-11-18 1 siteOther conditions: COVID-19 VaccineView official trial listing → -
Status unknown NCT NCT04694651
Potential Acceptance of COVID-19 Vaccines in Healthcare Workers in Egypt
Assiut University 400 participants Est. completion 2021-02-15 2 sitesOther conditions: Covid19View official trial listing → -
Completed NCT NCT04694664
COVID-19 Vaccine Confidence Among Pregnant Women and Mothers
Pregistry 18000 participants Est. completion 2020-12-01 1 siteOther conditions: Pregnancy Related, MothersView official trial listing → -
Completed NCT NCT04695652
A Study to Evaluate MVC-COV1901 Vaccine Against COVID-19 in Adult
Not yet reported Medigen Vaccine Biologics Corp. 3854 participants Est. completion 2021-10-29 12 sitesOther conditions: Covid19 VaccineView official trial listing → -
Completed NCT NCT04705116
COVID-19 Vaccines International Pregnancy Exposure Registry
Pregistry 1184 participants Est. completion 2026-04-26 1 siteOther conditions: Covid19View official trial listing → -
Status unknown NCT NCT04706156
Oral Side Effects of COVID-19 Vaccine
Masaryk University 1540 participants Est. completion 2021-03-31 4 sitesOther conditions: Oral Manifestations, Covid19, Vaccine Adverse ReactionView official trial listing → -
Completed NCT NCT04706403
Views on COVID-19 and Vaccination
Not yet reported University of Massachusetts, Worcester 756 participants Est. completion 2021-02-01 1 site Stand-aloneOther conditions: Covid19View official trial listing → -
Status unknown NCT NCT04713163
COVID-19 Vaccine Induced Immunity
University of Manitoba 200 participants Est. completion 2021-12Other conditions: Covid19View official trial listing → -
Withdrawn NCT NCT04718467
Phase IIb Clinical Trial of Recombinant Novel Coronavirus Pneumonia (COVID-19) Vaccine (Sf9 Cells)
Not yet reported Jiangsu Province Centers for Disease Control and Prevention Est. completion 2022-03-15 1 site Stand-aloneOther conditions: COVID-19View official trial listing → -
Completed NCT NCT04731870
Exploring Vaccine Confidence and Uptake of Potential COVID-19 Vaccines
East Carolina University 632 participants Est. completion 2023-03-31 1 siteOther conditions: CoronavirusView official trial listing → -
Status unknown NCT NCT04736524
Immune Response Following COVID-19 Vaccination
Texas Cardiac Arrhythmia Research Foundation 500 participants Est. completion 2022-03 1 siteOther conditions: IgM and IgG in BloodView official trial listing → -
Completed NCT NCT04748172
COVID-19 Vaccine and Ovarian Reserve
Sheba Medical Center 200 participants Est. completion 2023-06-01 1 siteOther conditions: Fertility Issues, Vaccine Adverse ReactionView official trial listing → -
Status unknown NCT NCT04748471
Immunogenecity and Safety of VaccinemRNA-1273 in Elderly Volunteers (Over 65 y) Compared to Younger Ones (18-45y)
Not yet reported Assistance Publique - Hôpitaux de Paris 180 participants Est. completion 2023-01-25Other conditions: Prevention of COVID19View official trial listing → -
Completed NCT NCT04751734
Impact of Maternal COVID-19 Vaccines on Breast Milk
Institute of Agrochemistry and Food Technology, National Research Council 120 participants Est. completion 2023-12-31 2 sitesOther conditions: COVID-19 VaccinesView official trial listing → -
Completed NCT NCT04754594
To Evaluate the Safety, Tolerability, and Immunogenicity of BNT162b2 Against COVID-19 in Healthy Pregnant Women 18 Years of Age and Older
Not yet reported, Not yet reported BioNTech SE 726 participants Est. completion 2022-07-15 90 sitesOther conditions: SARS-CoV-2 Infection, COVID-19, Maternal ImmunizationView official trial listing → -
Completed NCT NCT04754698
COVID-19 CoronaVac in Patients With Autoimmune Rheumatic Diseases and HIV/AIDS
Not yet reported University of Sao Paulo General Hospital 2196 participants Est. completion 2024-03-22 1 siteOther conditions: Rheumatic Disease, HIV Infections, AIDS, Safety Issues, Immunogenicity, COVID-19View official trial listing → -
Status unknown NCT NCT04756323
A Study to Evaluate Safety and Immunogenicity of Inactivated SARS-CoV-2 Vaccine (Vero Cells) in Healthy Population Aged 18 Years and Above(COVID-19)
Not yet reported Beijing Minhai Biotechnology Co., Ltd 1000 participants Est. completion 2022-02-28 1 siteOther conditions: COVID-19View official trial listing → -
Completed NCT NCT04760704
Covid-19 Vaccine Response in Elderly Subjects
University Hospital, Lille 264 participants Est. completion 2023-03-28 1 siteOther conditions: Covid19 VaccineView official trial listing → -
Completed NCT NCT04760730
Safety and Immunogenicity Study in Adults of AZD1222 and rAd26-S Administered as Heterologous Prime Boost Regimen for the Prevention of Coronavirus Disease 2019 (COVID-19)
Not yet reported, Not yet reported R-Pharm 100 participants Est. completion 2022-07-26 1 siteOther conditions: COVID-19View official trial listing → -
Withdrawn NCT NCT04761692
Increasing COVID-19, Influenza, and Pneumonia Vaccine Uptake
Not yet reported Charles Drew University of Medicine and Science Est. completion 2026-12-31 1 siteOther conditions: Covid19, Influenza, Pneumonia, Vaccine RefusalView official trial listing → -
Completed NCT NCT04761822
COVID19 SARS Vaccinations: Systemic Allergic Reactions to SARS-CoV-2 Vaccinations
Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 746 participants Est. completion 2022-04-27 29 sites Stand-aloneOther conditions: SARS-CoV Infection, COVID-19, Allergic Reaction, Mast Cell DisorderView official trial listing → -
Completed NCT NCT04764422
Assess the Safety and Immunogenicity of NDV-HXP-S Vaccine in Thailand
Not yet reported, Not yet reported Mahidol University 455 participants Est. completion 2022-09-12 1 siteOther conditions: Covid-19, SARS Pneumonia, Pneumonia, Viral, Covid-19 VaccineView official trial listing → -
Completed NCT NCT04765436
PTX-COVID19-B, an mRNA Humoral Vaccine, is Intended for Prevention of COVID-19 in a General Population. This Study is Designed to Evaluate Safety, Tolerability, and Immunogenicity of PTX-COVID19-B Vaccine in Healthy Seronegative Adults Aged 18-64
Not yet reported Providence Therapeutics Holdings Inc. 60 participants Est. completion 2022-03-30 1 siteOther conditions: Covid19 VaccineView official trial listing → -
Status unknown NCT NCT04769258
Effectiveness and Safety of COVID-19 Vaccine in Patients With IBD Treated With Immunomodulatory or Biological Drugs (ESCAPE-IBD)
Italian Group for the study of Inflammatory Bowel Disease (IG-IBD) 1380 participants Est. completion 2022-06-01Other conditions: Inflammatory Bowel DiseasesView official trial listing → -
Terminated NCT NCT04770649
Vaccine Observation to Include All Communities for Equitable Science
Persephone Biosciences 15 participants Est. completion 2022-12-31 1 siteOther conditions: Vaccine Response Impaired, Vaccine Adverse ReactionView official trial listing → -
Completed NCT NCT04771559
Evaluation of the Effect and Side Effect Profile of Covid-19 Vaccine in Cancer Patients
Not yet reported Bezmialem Vakif University 1500 participants Est. completion 2021-07-01 5 sitesOther conditions: Covid19, CancerView official trial listing → -
Terminated NCT NCT04773067
A Study to Evaluate UB-612 COVID-19 Vaccine in Adolescent, Younger and Elderly Adult Volunteers
Not yet reported United Biomedical Inc., Asia 3877 participants Est. completion 2022-03-08 12 sitesOther conditions: COVID-19View official trial listing → -
Completed NCT NCT04773665
Safety, Tolerability, and Immunogenicity of the COVID-19 Vaccine Candidates VBI-2902a and VBI-2905a
Not yet reported VBI Vaccines Inc. 114 participants Est. completion 2022-11-14 4 sites Stand-aloneOther conditions: Covid19View official trial listing → -
Completed NCT NCT04775069
Antibody Response to COVID-19 Vaccines in Liver Disease Patients
Not yet reported Humanity & Health Medical Group Limited 232 participants Est. completion 2023-09-30 1 siteOther conditions: Chronic Liver DiseaseView official trial listing → -
Completed NCT NCT04775563
COVID-19 Vaccine Hesitancy Among Rheumatic Diseases Patients
National Institute of Medical Sciences and Nutrition, Salvador Zubiran 891 participants Est. completion 2021-10-01 1 siteOther conditions: Covid19View official trial listing → -
Status unknown NCT NCT04776005
COVID-19 Vaccine Efficacy in Patients With Malignant Pathologies
Assistance Publique - Hôpitaux de Paris 500 participants Est. completion 2024-02 2 sitesOther conditions: Solid Tumor, Hematologic Malignancy, Thoracic Cancer, Cancer, Treatment-Related, Vaccine Response ImpairedView official trial listing → -
Completed NCT NCT04776317
Chimpanzee Adenovirus and Self-Amplifying mRNA Prime-Boost Prophylactic Vaccines Against SARS-CoV-2 in Healthy Adults
Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 81 participants Est. completion 2023-09-15 4 sitesOther conditions: COVID-19View official trial listing → -
Completed NCT NCT04779138
Increasing Vaccine Uptake in Underresourced Public Housing Areas
Not yet reported Charles Drew University of Medicine and Science 462 participants Est. completion 2024-04-01 1 site Stand-aloneOther conditions: Coronavirus, Vaccine RefusalView official trial listing → -
Completed NCT NCT04784689
Host Immune Response to Novel RNA COVID-19 Vaccination
The University of Texas Health Science Center at San Antonio 50 participants Est. completion 2022-05-18 1 siteOther conditions: COVID-19 Vaccine, CancerView official trial listing → -
Completed NCT NCT04785144
Safety and Immunogenicity Study of a SARS-CoV-2 (COVID-19) Variant Vaccine (mRNA-1273.351) in Naïve and Previously Vaccinated Adults
Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 135 participants Est. completion 2022-07-05 4 sitesOther conditions: COVID-19, COVID-19 ImmunisationView official trial listing → -
Completed NCT NCT04792567
Exploring the Immune Response to SARS-CoV-2 modRNA Vaccines in Patients With Secondary Progressive Multiple Sclerosis (AMA-VACC)
Not yet reported Novartis Pharmaceuticals 41 participants Est. completion 2022-08-15 10 sitesOther conditions: Secondary Progressive Multiple SclerosisView official trial listing → -
Completed NCT NCT04794829
Natural History of Systemic and Nasal Mucosal Immunity to Influenza and SARS-CoV-2 in Adults After Vaccination
National Institute of Allergy and Infectious Diseases (NIAID) 75 participants Est. completion 2026-07-28 1 siteOther conditions: Influenza, COVID-19View official trial listing → -
Status unknown NCT NCT04794946
Safety and Efficacy of a Non-replicating ChAdOx1 Vector Vaccine AZD1222 (COVISHIELD), for Prevention of COVID-19 in Patients With Liver Cirrhosis
Not yet reported Institute of Liver and Biliary Sciences, India 2200 participants Est. completion 2022-03-19 1 siteOther conditions: Liver CirrhosisView official trial listing → -
Status unknown NCT NCT04798001
Safety and Immunogenicity of an Intranasal RSV Vaccine Expressing SARS-CoV-2 Spike Protein (COVID-19 Vaccine) in Adults
Not yet reported Meissa Vaccines, Inc. 130 participants Est. completion 2022-10-31 2 sitesOther conditions: Covid19View official trial listing → -
Active, not recruiting NCT NCT04798625
Vaccine Response to COVID-19 Vaccines in Patients Using Immunosuppressive Medication
Diakonhjemmet Hospital 2300 participants Est. completion 2027-02-15 2 sitesOther conditions: Rheumatoid Arthritis, Psoriatic Arthritis, Spondyloarthritis, Crohn Disease, Ulcerative Colitis, Autoimmune Hepatitis, Liver Transplant; ComplicationsView official trial listing → -
Terminated NCT NCT04799392
NOWDx Test for the Detection of Antibodies to COVID-19 in Lay Persons
Not yet reported NOWDiagnostics, Inc. 50 participants Est. completion 2021-10-28 5 sites Stand-aloneOther conditions: COVID-19, SARS-CoV-2, CoronavirusView official trial listing → -
Status unknown NCT NCT04800133
Covid-19 Vaccination in Adolescents and Children
Not yet reported The University of Hong Kong 1018 participants Est. completion 2025-03-31 1 siteOther conditions: Covid19View official trial listing → -
Status unknown NCT NCT04801030
COVID-19 Vaccine Hesitancy Among African Americans
Not yet reported Meharry Medical College 300 participants Est. completion 2022-09-30 1 siteOther conditions: Covid19, Vaccine Refusal, CommunicationView official trial listing → -
Status unknown NCT NCT04802278
Gestational Immunity for Transfer
National University Hospital, Singapore 120 participants Est. completion 2021-12-01 1 siteOther conditions: Covid19, Breastfeeding, Vaccine Exposure Via Breast MilkView official trial listing → -
Completed NCT NCT04805216
Covid-19 Vaccine Response in Immunocompromised Haematology Patients
University Hospitals of North Midlands NHS Trust 75 participants Est. completion 2022-07-31 1 siteOther conditions: Covid19, Haematological Disorders, Immune SuppressionView official trial listing → -
Completed NCT NCT04806113
COVID-19 Vaccine in Immunosuppressed Adults With Autoimmune Diseases
Not yet reported McGill University Health Centre/Research Institute of the McGill University Health Centre 220 participants Est. completion 2022-06-15 1 siteOther conditions: Covid19, Rheumatic Diseases, Rheumatoid Arthritis, SLEView official trial listing → -
Status unknown NCT NCT04809948
Effects of COVID 19 Vaccine on Egyptian Population
Assiut University 800 participants Est. completion 2021-12-30Other conditions: COVID 19 VaccineView official trial listing → -
Status unknown NCT NCT04813562
Immunogenicity and Safety of Recombinant COVID-19 Vaccine (CHO Cells)
Not yet reported Jiangsu Province Centers for Disease Control and Prevention 480 participants Est. completion 2022-07-30 1 site Stand-aloneOther conditions: COVID-19View official trial listing → -
Completed NCT NCT04816019
A Study of Intranasal ChAdOx1 nCOV-19
Not yet reported University of Oxford 42 participants Est. completion 2022-09-30 1 site Stand-aloneOther conditions: CoronavirusView official trial listing → -
No Longer Available NCT NCT04817657
Pre-approval Access for Janssen's COVID Vaccine VAC31518 for Treating Physician Use
Janssen Research & Development, LLCOther conditions: HealthyView official trial listing → -
Completed NCT NCT04818801
Safety, Reactogenicity and Immunogenicity Study of ReCOV
Not yet reported Jiangsu Rec-Biotechnology Co., Ltd. 100 participants Est. completion 2022-05-05 2 sites Stand-aloneOther conditions: Covid19View official trial listing → -
Completed NCT NCT04818892
Immunogenicity of COVID-19 Vaccine in Patients With Inflammatory Bowel Disease
University of Wisconsin, Madison 222 participants Est. completion 2022-11-11 1 siteOther conditions: IBD, Covid19 VaccineView official trial listing → -
Status unknown NCT NCT04822012
Anti COVID-19 Antibodies in Follicular Fluid and Spermatic Fluid
Meir Medical Center 50 participants Est. completion 2021-06-01 1 siteOther conditions: SARS-CoV-2View official trial listing → -
Completed NCT NCT04824651
Covid-19 Vaccine Cohort in Specific Populations
ANRS, Emerging Infectious Diseases 6922 participants Est. completion 2024-12-11 3 sitesOther conditions: Immune DeficiencyView official trial listing → -
Status unknown NCT NCT04828460
Monitoring of COVID-19 Vaccine Response in Organ Transplant Patients
University Hospital, Strasbourg, France 3500 participants Est. completion 2023-02 1 siteOther conditions: Covid19, Kidney TransplantationView official trial listing → -
Status unknown NCT NCT04832932
The COVID-19 Back-to-Normal Study: Analysis of Multiple Outcomes
Mebo Research, Inc. 2000 participants Est. completion 2025-01-05 5 sitesOther conditions: COVID-19 VaccinesView official trial listing → -
Completed NCT NCT04837651
Humoral and T-Cell Responses to COVID-19 Vaccination in Multiple Sclerosis Patients Treated With Ocrelizumab Treated With Ocrelizumab or Natalizumab
Dragonfly Research, LLC 48 participants Est. completion 2021-07-01 1 siteOther conditions: Multiple Sclerosis, Demyelinating Autoimmune Diseases, CNS, Autoimmune Diseases of the Nervous System, Nervous System Diseases, Demyelinating Diseases, Autoimmune Diseases, Immune System Diseases, Pathologic ProcessesView official trial listing → -
Status unknown NCT NCT04838080
Safety and Immunogenicity of the Inactivated Koçak-19 Inaktif Adjuvanlı COVID-19 Vaccine Compared to Placebo
Not yet reported Kocak Farma 38 participants Est. completion 2021-10-20 1 site Stand-aloneOther conditions: COVID-19 VaccineView official trial listing → -
Completed NCT NCT04838795
Sisonke (Together): OPEN LABEL TRIAL COVID-19
Not yet reported Wits Health Consortium (Pty) Ltd 477102 participants Est. completion 2022-03-31 31 sitesOther conditions: SARS (Severe Acute Respiratory Syndrome)View official trial listing → -
Completed NCT NCT04839146
Safety and Tolerability of COVID-19 Vaccine (ABNCoV2)
Not yet reported Radboud University Medical Center 45 participants Est. completion 2022-02-25 1 siteOther conditions: Covid19, Severe Acute Respiratory Syndrome, SARS-CoV-2 InfectionView official trial listing → -
Completed NCT NCT04840992
Phase I/II Clinical Trial of Recombinant Novel Coronavirus (COVID-19) Vaccine (Adenovirus Type 5 Vector) for Inhalation
Not yet reported, Not yet reported CanSino Biologics Inc. 840 participants Est. completion 2022-08-09 1 siteOther conditions: COVID-19View official trial listing → -
Completed NCT NCT04843774
Vaccine-generated Immunity in Ocrelizumab-treated Patients: Longitudinal Assessments (VIOLA)
NYU Langone Health 64 participants Est. completion 2023-04-18 2 sitesOther conditions: Multiple SclerosisView official trial listing → -
Completed NCT NCT04843917
Immunity Against COVID-19 Vaccine in Healthcare Workers in Argentine
Hospital Italiano de Buenos Aires 100 participants Est. completion 2023-08-09 1 siteOther conditions: Coronavirus 2019, Healthcare Workers, VaccineView official trial listing → -
Terminated NCT NCT04844346
Plant Stanol Esters and COVID-19 Vaccination Response
Not yet reported Maastricht University Medical Center 48 participants Est. completion 2022-01-11 1 site Stand-aloneOther conditions: Overweight and ObesityView official trial listing → -
Completed NCT NCT04845048
Active Pharmacovigilance Study of Adsorbed COVID-19 (Inactivated) Vaccine
Butantan Institute 2549 participants Est. completion 2023-03-13 3 sitesOther conditions: SARS-CoV-2 Acute Respiratory DiseaseView official trial listing → -
Withdrawn NCT NCT04845191
COVID-19 Subcutaneously and Orally Administered Supplemental Vaccine Boost to Enhance T Cell Protection in Those Who Have Already Received EUA S-Based Vaccines
Not yet reported, Not yet reported ImmunityBio, Inc. Est. completion 2021-12-14Other conditions: Covid19View official trial listing → -
Status unknown NCT NCT04845997
COVID-19 Vaccination in Patients With Rheumatic Diseases
Sociedad Argentina de Reumatologia 3000 participants Est. completion 2023-12-31 2 sitesOther conditions: Rheumatic DiseasesView official trial listing → -
Completed NCT NCT04847596
A Multicenter Study to Assess Response to COVID-19 Vaccine in Multiple Sclerosis Participants Treated With Ofatumumab
Novartis Pharmaceuticals 25 participants Est. completion 2022-02-18 5 sitesOther conditions: Relapsing Multiple SclerosisView official trial listing → -
Withdrawn NCT NCT04848467
COVID-19: A Trial Studying the SARS-CoV-2 mRNA Vaccine CVnCoV to Learn About the Immune Response, the Safety, and the Degree of Typical Vaccination Reactions When CVnCoV is Given at the Same Time as a Flu Vaccine Compared to When the Vaccines Are Separately Given in Adults 60 Years of Age and Older
Not yet reported Bayer Est. completion 2022-11-15Other conditions: SARS-CoV-2 Infection, Coronavirus Disease 2019 (COVID-19)View official trial listing → -
Completed NCT NCT04848493
National Project on Vaccines, COVID-19 and Frail Patients
Azienda USL Reggio Emilia - IRCCS 747 participants Est. completion 2022-12-31 12 sitesOther conditions: COVID-19, Solid Tumor, Hematologic Diseases, Neurologic Disorder, Rheumatic DiseasesView official trial listing → -
Status unknown NCT NCT04852705
A Study to Evaluate the Efficacy, Safety and Immunogenicity of SARS-CoV-2 Vaccine (Vero Cells), Inactivated in Healthy Adults Aged 18 Years and Older (COVID-19)
Not yet reported Shenzhen Kangtai Biological Products Co., LTD 28000 participants Est. completion 2022-11Other conditions: COVID-19View official trial listing → -
Completed NCT NCT04852978
COVID-19 Study to Assess Immunogenicity, Safety, and Tolerability of Moderna mRNA-1273 Vaccine Administered With Casirivimab+Imdevimab in Healthy Adult Volunteers
Not yet reported Regeneron Pharmaceuticals 295 participants Est. completion 2022-11-21 6 sitesOther conditions: Healthy, Chronic Stable IllnessView official trial listing → -
Completed NCT NCT04854408
Evaluation of the Effect of Coronavac Vaccine (Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2 Vaccine) on Healthcare Workers' Menstrual Patterns
Kanuni Sultan Suleyman Training and Research Hospital 300 participants Est. completion 2021-05-09 1 siteOther conditions: Covid19, Vaccine Reaction, Coronavirus, Menstrual Problem, EndometriumView official trial listing → -
Withdrawn NCT NCT04854876
Pilot Study to Evaluate the Safety, Tolerability, and Efficacy of 5-ALA-Phosphate + SFC as an Immune System Enhancer Along With Vaccination Against COVID-19
Not yet reported Royal College of Surgeons in Ireland - Medical University of Bahrain Est. completion 2021-08-30 Stand-aloneOther conditions: SARS-COV 2, Covid19View official trial listing → -
Completed NCT NCT04858568
Immune Responses to COVID-19 Vaccination in Lymphoma Patients
University Hospital Southampton NHS Foundation Trust 592 participants Est. completion 2024-01-31 9 sitesOther conditions: Classical Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma, Primary Mediastinal B Cell Lymphoma, High-grade B-cell Lymphoma, Burkitt Lymphoma, Follicular Lymphoma, Mantle Cell Lymphoma, Marginal Zone Lymphoma, Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Lymphoplasmacytic Lymphoma, Nodular Lymphocyte Predominant Hodgkin Lymphoma, Peripheral T-cell LymphomaView official trial listing → -
Completed NCT NCT04858607
Humoral and Cellular Immune Response to COVID-19 Vaccines in Immunocompromised and Healthy Individuals
Medical University of Graz 373 participants Est. completion 2023-01-20 1 siteOther conditions: Covid19, ImmunosuppressionView official trial listing → -
Completed NCT NCT04860297
A Study to Evaluate Safety and Immunogenicity of mRNA-1273 Vaccine to Prevent COVID-19 in Adult Organ Transplant Recipients and in Healthy Adult Participants
Not yet reported ModernaTX, Inc. 234 participants Est. completion 2023-05-22 15 sites Stand-aloneOther conditions: SARS-CoV-2View official trial listing → -
Status unknown NCT NCT04860908
COVID 19 ANTOBODIES IN PREGNANT WOMEN AND THEIR CONNECTION TO BETA CELL FUNCTION IN THE FETUS
Maaynei Hayesha Medical Center 100 participants Est. completion 2022-07-01 1 siteOther conditions: Generation of Anti COVID-19 Antibodies in a Fetus, Whose Mother Was Exposed to COVID or Was Vaccinated During PregnancyView official trial listing → -
Status unknown NCT NCT04863638
A Immuno-bridging and Immunization Schedules Study of COVID-19 Vaccine (Vero Cell), Inactivated
Not yet reported China National Biotec Group Company Limited 4400 participants Est. completion 2024-03-31 1 site Stand-aloneOther conditions: Covid19View official trial listing → -
Completed NCT NCT04864561
COV-COMPARE Immunogenicity of Vaccine VLA2001 Compared to AZD1222
Not yet reported Valneva Austria GmbH 4034 participants Est. completion 2023-03-13 31 sitesOther conditions: SARS-CoV-2 Virus InfectionView official trial listing → -
Completed NCT NCT04865133
Efficacy and Safety of COVID-19 Vaccine in Cancer Patients
Mayo Clinic 89 participants Est. completion 2022-09-08 1 siteOther conditions: COVID-19 Infection, Malignant Solid NeoplasmView official trial listing → -
Status unknown NCT NCT04865900
Prevalence of Perimyocarditis After Covid-19 Vaccine
Hillel Yaffe Medical Center 500 participants Est. completion 2022-04 1 siteOther conditions: Perimyocarditis, Covid19View official trial listing → -
Status unknown NCT NCT04868448
COVID-19 Vaccine Effectiveness Among Health Workers in Georgia
National Center for Disease control and Public Health 1600 participants Est. completion 2022-08-01 6 sitesOther conditions: Covid19View official trial listing → -
Completed NCT NCT04869358
Exploring the Immune Response to SARS-CoV-2 COVID-19 Vaccines in Patients With Relapsing Multiple Sclerosis (RMS) Treated With Ofatumumab
Not yet reported Novartis Pharmaceuticals 34 participants Est. completion 2023-06-13 6 sitesOther conditions: Relapsing Multiple SclerosisView official trial listing → -
Terminated NCT NCT04870411
Immunological Response to COVID-19 Vaccine in Patients With Autoimmune and Inflammatory Diseases Treated With Immunosuppressants and/or Biologics
Assistance Publique - Hôpitaux de Paris 78 participants Est. completion 2022-03-13 1 siteOther conditions: Autoimmune Diseases, Inflammatory DisorderView official trial listing → -
Status unknown NCT NCT04871165
Analysis of Immunogenicity, Safety and Efficacy of COVID-19 Vaccines in Immunosuppressed Individuals
Vilnius University 3270 participants Est. completion 2024-03-01 1 siteOther conditions: Hematologic Neoplasms, COVID-19 VaccinesView official trial listing → -
Status unknown NCT NCT04876885
The Future of Viral Communications: Video-Based Health Promotion Strategies for COVID-19 Vaccinations
Not yet reported McMaster University 100 participants Est. completion 2021-06-06Other conditions: Health Promotion, Health Education, COVID-19 VaccinesView official trial listing → -
Status unknown NCT NCT04877496
Responses to COVID19 Vaccination in Patients With a Treatment History of Rituximab.
Insel Gruppe AG, University Hospital Bern 425 participants Est. completion 2021-10-31 1 siteOther conditions: COVID19 Vaccination, Rituximab, ImmunosuppressionView official trial listing → -
Terminated NCT NCT04878211
A Open-label Study to Assess Response to COVID-19 Vaccine in Multiple Sclerosis Participants Treated With Ofatumumab
Not yet reported Novartis Pharmaceuticals 24 participants Est. completion 2023-04-14 7 sites Stand-aloneOther conditions: Relapsing Multiple Sclerosis (RMS)View official trial listing → -
Completed NCT NCT04881396
Response of Haemodialysis Patients to BNT162b2 mRNA Cov-19 Vaccine
Hospices Civils de Lyon 99 participants Est. completion 2022-02-15 2 sitesOther conditions: COVID-19 Vaccines, Hemodialysis ComplicationView official trial listing → -
Status unknown NCT NCT04885764
Profiling Antibody Status and Vaccine Effectiveness in Post Vaccination With SARS CoV2 in Ain Shams University
Not yet reported, Not yet reported Ain Shams University 4000 participants Est. completion 2021-12-01 1 siteOther conditions: Covid19View official trial listing → -
Completed NCT NCT04885907
Third Dose of Moderna COVID-19 Vaccine in Transplant Recipients
Not yet reported University Health Network, Toronto 120 participants Est. completion 2021-08-30 2 sitesOther conditions: Vaccine Response Impaired, Immune Suppression, Covid19View official trial listing → -
Completed NCT NCT04887129
Testing for COVID-19 in High Risk Children With Intellectual and Developmental Disabilities (COV-IDD)
Not yet reported University of Rochester 392 participants Est. completion 2024-03-31 1 site Stand-aloneOther conditions: Covid19View official trial listing → -
Completed NCT NCT04892459
Study on Sequential Immunization of Inactivated SARS-CoV-2 Vaccine and Recombinant SARS-CoV-2 Vaccine (Ad5 Vector)
Not yet reported Jiangsu Province Centers for Disease Control and Prevention 300 participants Est. completion 2021-12-25 1 siteOther conditions: COVID-19View official trial listing → -
Completed NCT NCT04894435
Mix and Match of the COVID-19 Vaccine for Safety and Immunogenicity
Not yet reported Canadian Immunization Research Network 669 participants Est. completion 2023-06-16 8 sitesOther conditions: COVID-19View official trial listing → -
Status unknown NCT NCT04894448
Immunogenicity of COVID-19 Vaccination in PLWH
CIHR Canadian HIV Trials Network 500 participants Est. completion 2023-07-31 3 sitesOther conditions: HIV InfectionsView official trial listing → -
Status unknown NCT NCT04895007
Comparative Evaluation of Covid-19 Vaccines Response
Karamanoğlu Mehmetbey University 1500 participants Est. completion 2022-06-01 4 sitesOther conditions: COVID-19 VaccinesView official trial listing → -
Status unknown NCT NCT04900467
Compare Immunological Efficacy of a Vaccine Regimen Combining Two Covid19 mRNA Vaccines (Pfizer-BioNTech and Moderna) With That of a Homologous Vaccination of Each Covid19 mRNA Vaccine
Not yet reported Assistance Publique - Hôpitaux de Paris 418 participants Est. completion 2022-01 1 site Stand-aloneOther conditions: Adult Who Received a First Dose of an mRNA Vaccine (Pfizer-BioNTech or Moderna) and Need to Receive a Second DoseView official trial listing → -
Completed NCT NCT04904744
Effect of Varied Outreach Methods on Appointment Scheduling, Appointment Completion, and Receipt of COVID-19 Vaccination
Not yet reported Children's Hospital Medical Center, Cincinnati 1235 participants Est. completion 2021-12-10 1 siteOther conditions: Health Care Utilization, Vaccine Preventable DiseaseView official trial listing → -
Completed NCT NCT04910295
Immunogenicity and Safety of COVID-19 Vaccine in Cancer Patients
Seoul National University Hospital 112 participants Est. completion 2022-12-31 1 siteOther conditions: Cancer, Covid19View official trial listing → -
Status unknown NCT NCT04910971
Quantification of Binding and Neutralizing Antibody Levels in COVID-19 Vaccinated Health Care Workers Over 1 Year
LifeBridge Health 60 participants Est. completion 2022-07-28 1 siteOther conditions: COVID-19 Vaccine, Corona Virus Infection, Vaccine Adverse Reaction, Vaccine Response, Inflammation, ThrombosisView official trial listing → -
Completed NCT NCT04912700
The Impact of Vaccination on Severity of Illness in COVID-19
Corewell Health East 11834 participants Est. completion 2021-06-07 1 siteOther conditions: Covid19View official trial listing → -
Completed NCT NCT04918888
COVID-19 Vaccination in Oncologic Patients
Krankenhaus Barmherzige Schwestern Linz 1150 participants Est. completion 2021-09-30 2 sitesOther conditions: Covid19, Oncologic DisordersView official trial listing → -
Completed NCT NCT04922944
Post COVID-19 Vaccination Analysis in Healthcare Worker Recipients
Huntington Memorial Hospital 167 participants Est. completion 2022-03-01 1 siteOther conditions: Covid19, Vaccine ReactionView official trial listing → -
Active, not recruiting NCT NCT04924803
Community Developed Technology-Based Messaging to Increase COVID-19 Vaccine Uptake Among People Who Inject Drugs
Not yet reported NDRI-USA, Inc. 545 participants Est. completion 2026-02-27 1 siteOther conditions: Covid19View official trial listing → -
Completed NCT NCT04927065
A Study to Evaluate the Immunogenicity and Safety of mRNA Vaccine Boosters for SARS-CoV-2 (COVID-19) Variants
Not yet reported, Not yet reported ModernaTX, Inc. 5161 participants Est. completion 2023-11-17 23 sitesOther conditions: SARS-CoV-2View official trial listing → -
Withdrawn NCT NCT04930770
Study About the Response to the Administration of a Third Dose of mRNA-1273 Vaccine (COVID-19 Vaccine Moderna) in Renal Transplants With Immunological Failure Initial to Vaccination
Not yet reported Maria Joyera Rodríguez Est. completion 2022-03-01Other conditions: Covid19View official trial listing → -
Completed NCT NCT04932863
BNT162b2 Messenger Ribonucleic Acid (mRNA) Covid-19 Vaccine in Cancer Patients on Active Treatment
Ente Ospedaliero Ospedali Galliera 300 participants Est. completion 2023-03-15 1 siteOther conditions: Neoplasms, Cancer, Treatment-RelatedView official trial listing → -
Status unknown NCT NCT04939155
Methylation Effects of COV-19 Infection and Vaccinations
TruDiagnostic 60 participants Est. completion 2022-03-10 1 siteOther conditions: Covid19View official trial listing → -
Completed NCT NCT04939506
COVID-19 Vaccine Education at the Point of Testing to Increase Vaccine Uptake in Vulnerable Communities in SE Louisiana
Not yet reported Xavier University of Louisiana. 377 participants Est. completion 2024-01-25 1 site Stand-aloneOther conditions: Covid19, Vaccine Refusal, Vaccine HesitancyView official trial listing → -
Completed NCT NCT04939519
SCALE-UP Utah: Community-Academic Partnership to Address COVID-19 Vaccination Rates Among Utah Community Health Centers
Not yet reported University of Utah 65300 participants Est. completion 2023-02-28 1 siteOther conditions: Covid19View official trial listing → -
Completed NCT NCT04942405
Efficacy, Immunogenicity, and Safety of the Inactivated COVID-19 Vaccine (TURKOVAC) Versus the CoronaVac Vaccine
Not yet reported Health Institutes of Turkey 1290 participants Est. completion 2024-02-01 29 sitesOther conditions: Covid19View official trial listing → -
Status unknown NCT NCT04944381
Study of Ameliorating Effect of COVID-19 mRNA Vaccine in Individuals Immunized With Inactivated Vaccine
Not yet reported Qihan Li 112 participants Est. completion 2022-08-02Other conditions: SARS-CoV-2 Acute Respiratory DiseaseView official trial listing → -
Completed NCT NCT04944433
Safety and Efficacy of the Coronavirus Disease 2019 Vaccine in Hemodialysis Patients
Hospital Italiano de Buenos Aires 950 participants Est. completion 2022-08-04 1 siteOther conditions: Coronavirus Disease 2019 Vaccines, Renal DialysisView official trial listing → -
Completed NCT NCT04949490
A Trial Investigating the Safety and Effects of One or Two Additional Doses of Comirnaty or One Dose of BNT162b2s01 in BNT162-01 or BNT162-04 Trial Subjects
Not yet reported BioNTech SE 137 participants Est. completion 2022-09-16 4 sitesOther conditions: COVID-19, SARS-CoV-2 InfectionView official trial listing → -
Status unknown NCT NCT04951323
Impact of the Immune System on Response to Anti-Coronavirus Disease 19 (COVID-19) Vaccine in Allogeneic Stem Cell Recipients (Covid Vaccin Allo)
Not yet reported University of Liege 50 participants Est. completion 2023-01-01 1 siteOther conditions: Coronavirus Disease 2019 (Covid19), Hematopoietic NeoplasmsView official trial listing → -
Completed NCT NCT04951388
A Study to Evaluate MVC-COV1901 Vaccine Against COVID-19 in Adolescents
Not yet reported Medigen Vaccine Biologics Corp. 399 participants Est. completion 2022-03-21 5 sitesOther conditions: Covid19 VaccineView official trial listing → -
Completed NCT NCT04952376
Equitable Access to COVID-19 Vaccines
Not yet reported Mayo Clinic 1722 participants Est. completion 2021-06-10 1 site Stand-aloneOther conditions: Covid19View official trial listing → -
Status unknown NCT NCT04954131
Immunogenicity and Safety Study of Adjuvanted SARS-CoV-2 (SCB-2019) Vaccine in Adultsin China
Not yet reported Zhejiang Clover Biopharmaceuticals, Inc. 766 participants Est. completion 2022-11-15 2 sitesOther conditions: COVID-19View official trial listing → -
Completed NCT NCT04954287
Phase 1 Study of Intranasal PIV5 COVID-19 Vaccine Expressing SARS-CoV-2 Spike Protein in Healthy Adults and Adolescents
Not yet reported CyanVac LLC 72 participants Est. completion 2023-06-10 4 sitesOther conditions: Covid19View official trial listing → -
Completed NCT NCT04954469
B-pVAC-SARS-CoV-2: Study to Prevent COVID-19 Infection in Adults With Bcell/ Antibody Deficiency
Not yet reported, Not yet reported University Hospital Tuebingen 54 participants Est. completion 2023-04-30 3 sitesOther conditions: Immune Deficiency DiseaseView official trial listing → -
Completed NCT NCT04956562
Effect of Sinovac on Survival in Intensive Care Unit
Sisli Hamidiye Etfal Training and Research Hospital 96 participants Est. completion 2021-05-15 1 siteOther conditions: Survival, Intensive Care UnitView official trial listing → -
Terminated NCT NCT04958304
Moderna COVID-19 Vaccine mRNA-1273 Observational Pregnancy Outcome Study
ModernaTX, Inc. 20 participants Est. completion 2023-09-22 1 siteOther conditions: SARS-CoV-2View official trial listing → -
Completed NCT NCT04958954
Post-Marketing Safety Study of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) mRNA-1273 COVID-19 Vaccine in the United States
ModernaTX, Inc. 50000000 participants Est. completion 2023-06-30 1 siteOther conditions: SARS-CoV-2View official trial listing → -
Status unknown NCT NCT04961229
Booster Dose of COVID-19 Vaccine for Kidney Transplant Recipients Without Adequate Humoral Response
Not yet reported dafna yahav 504 participants Est. completion 2022-07Other conditions: COVID-19 Acute Respiratory Distress Syndrome, ImmunosuppressionView official trial listing → -
Completed NCT NCT04962906
Study to Evaluate the Immunogenicity and Safety of Heterologous SARS-CoV-2 Vaccine Schemes
Not yet reported Ministerio de Salud de Ciudad Autónoma de Buenos Aires 192 participants Est. completion 2021-08-15 1 siteOther conditions: COVID-19 VaccinesView official trial listing → -
Terminated NCT NCT04963790
Enabling Family Physicians to Reduce Vaccine Hesitancy and Increase Covid-19 Vaccine Uptake
Not yet reported Hopital Montfort 12 participants Est. completion 2023-07-14 1 site Stand-aloneOther conditions: Covid19, COVID-19 VaccineView official trial listing → -
Completed NCT NCT04967742
A Extension Study to Evaluate the Safety, Tolerability, and Immunogenicity of UB-612 COVID-19 Vaccine
Not yet reported United Biomedical Inc., Asia 50 participants Est. completion 2021-10-31 1 siteOther conditions: COVID-19View official trial listing → -
Completed NCT NCT04969601
Anti-Covid-19 Vaccine in Children With Acute Leukemia and Their Siblings
Not yet reported, Not yet reported Assistance Publique - Hôpitaux de Paris 76 participants Est. completion 2024-03-01 2 sitesOther conditions: Acute Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid LeukemiaView official trial listing → -
Completed NCT NCT04973449
Phase II/III Study of AZD2816, for the Prevention of COVID-19 in Adults
Not yet reported, Not yet reported AstraZeneca 2843 participants Est. completion 2022-08-02 35 sitesOther conditions: COVID-19, SARS-CoV-2View official trial listing → -
Completed NCT NCT04974164
Effectiveness of COVID-19 Vaccine for Prevention of COVID-19 in the Dominican Republic
Sinovac Research and Development Co., Ltd. 1400 participants Est. completion 2021-12-13 10 sitesOther conditions: COVID-19View official trial listing → -
Active, not recruiting NCT NCT04977024
SARS-CoV-2 Vaccine (GEO-CM04S1) Versus mRNA SARS-COV-2 Vaccine in Patients With Blood Cancer
Not yet reported GeoVax, Inc. 63 participants Est. completion 2027-12-31 6 sitesOther conditions: COVID-19 Infection, Hematopoietic and Lymphoid System Neoplasm, Leukemia, Lymphoma, Plasma Cell MyelomaView official trial listing → -
Completed NCT NCT04981392
Trusted Messengers: Intervention to Promote COVID-19 Vaccination
Not yet reported University of Massachusetts, Worcester 21844 participants Est. completion 2023-10-25 1 siteOther conditions: Covid19, VaccinationView official trial listing → -
Terminated NCT NCT04981405
Real-world Evidence of COVID-19 Vaccines Effectiveness
Ivan S Moiseev 182 participants Est. completion 2022-07-19 2 sitesOther conditions: COVID-19 PneumoniaView official trial listing → -
Status unknown NCT NCT04983537
Study to Evaluate the Immunogenicity and Safety of Heterologous SARS-CoV-2 Vaccine Schemes in an Elderly Population
Not yet reported Ministerio de Salud de Ciudad Autónoma de Buenos Aires 120 participants Est. completion 2021-09-26 2 sitesOther conditions: COVID-19 VaccinesView official trial listing → -
Status unknown NCT NCT04988048
Collaborative Study to Evaluate Heterologous Vaccination Against Covid-19 in Argentina
Not yet reported Ministry of Public Health, Argentina 1760 participants Est. completion 2022-02-15 4 sitesOther conditions: COVID-19 VACCINE, Covid19View official trial listing → -
Status unknown NCT NCT04992182
Reactogenicity, Safety, and Immunogenicity of Covid-19 Vaccine Booster
Not yet reported Universidad del Desarrollo 534 participants Est. completion 2022-06-30 2 sitesOther conditions: Covid19View official trial listing → -
Completed NCT NCT04992195
Impact of COVID-19 Vaccines on Cerebrovascular Health
Chinese University of Hong Kong 415 participants Est. completion 2026-03-31 1 siteCardiovascular disease Other conditions: Dementia, Brain Ischemia, Alzheimer Disease, Brain Diseases, Major Adverse Cardiovascular Event, Arterial Thromboembolism, Venous ThromboembolismView official trial listing → -
Completed NCT NCT04993209
Clinical Trial of the COVID-19 Vaccine (Recombinant, Inactivated) in Brazil
Not yet reported Butantan Institute 320 participants Est. completion 2022-11-04 1 siteOther conditions: Coronavirus Infections, HealthyView official trial listing → -
Withdrawn NCT NCT04993326
Advancing DSME/S and COVID-19 Prevention and Protection Through "emPOWERed to Change" Program
Not yet reported Charles Drew University of Medicine and Science Est. completion 2023-02-28Type 2 diabetes Other conditions: Covid19View official trial listing → -
Status unknown NCT NCT04998240
Mix and Match Heterologous Prime-Boost Study Using Approved COVID-19 Vaccines
Not yet reported International Vaccine Institute 360 participants Est. completion 2024-02-28 2 sitesOther conditions: Covid19View official trial listing → -
Terminated NCT NCT05000216
COVID-19 Booster Vaccine in Autoimmune Disease Non-Responders
Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 258 participants Est. completion 2024-03-28 29 sites Stand-aloneOther conditions: Rheumatoid Arthritis (RA), Systemic Lupus Erythematosus (SLE), Pemphigus Vulgaris, Multiple Sclerosis (MS), Systemic Sclerosis (SSc), Pediatric SLE, Juvenile Idiopathic Arthritis (JIA), Juvenile Dermatomyositis (JDM), Pediatric-Onset Multiple Sclerosis (POMS)View official trial listing → -
Completed NCT NCT05004181
Safety and Immunogenicity of RNA-based Vaccines Against SARS-CoV-2 Variants in Healthy Participants
Not yet reported BioNTech SE 1380 participants Est. completion 2023-10-04 35 sitesOther conditions: SARS-CoV-2 Infection, COVID-19, SARS-CoV-2 Acute Respiratory Disease, SARS (Disease)View official trial listing → -
Completed NCT NCT05007080
A Study to Evaluate Different Dose Levels of Ad26.COV2.S in Healthy Adolescents From 12 to 17 Years Inclusive
Not yet reported Janssen Vaccines & Prevention B.V. 304 participants Est. completion 2023-08-14 18 sitesOther conditions: Coronavirus Disease-2019 (COVID-19) PreventionView official trial listing → -
Completed NCT NCT05007860
Vaccine Responsiveness in Patients With Chronic Lymphocytic Leukemia
Massachusetts General Hospital 36 participants Est. completion 2023-06-30 1 siteOther conditions: Chronic Lymphocytic Leukemia/Small Lymphocytic LymphomaView official trial listing → -
Completed NCT NCT05009030
Anti-SARS-COV2 Vaccination Study in Lung Cancer Patients
Fundación GECP 794 participants Est. completion 2022-03-28 51 sitesOther conditions: Lung Cancer, Covid19View official trial listing → -
Status unknown NCT NCT05012800
Safety and Immunogenicity of COVID-19 Vaccine Administered in Older Adults
Not yet reported Beijing 302 Hospital 300 participants Est. completion 2022-09-30 1 site Stand-aloneOther conditions: COVID-19 Vaccine, Older AdultsView official trial listing → -
Withdrawn NCT NCT05013983
Clinical Trial of Recombinant COVID-19 Vaccine (Sf9 Cells) in Children and Adolescents
Not yet reported, Not yet reported WestVac Biopharma Co., Ltd. Est. completion 2025-12 1 site Stand-aloneOther conditions: COVID-19View official trial listing → -
Enrolling by invitation NCT NCT05015881
Relationship Between Brain and Heart Glucose Metabolism in Alcohol Use Disorder
Not yet reported, Not yet reported University of Pennsylvania 20 participants Est. completion 2027-12 1 siteAlcohol use disorderView official trial listing → -
Terminated NCT NCT05016622
Booster Dose Trial
Not yet reported Montefiore Medical Center 106 participants Est. completion 2023-05-21 1 siteOther conditions: CancerView official trial listing → -
Status unknown NCT NCT05017805
COVID-19 Vaccines in Patients With Chronic Liver Disease
Not yet reported Beijing 302 Hospital 300 participants Est. completion 2025-08-15 1 site Stand-aloneOther conditions: Liver Disease ChronicView official trial listing → -
Completed NCT NCT05020145
COVID-19 Vaccination and Breakthrough Infections Among Persons With Immunocompromising Conditions in the United States
Pfizer 1277747 participants Est. completion 2021-12-17 1 siteOther conditions: Immunocompromised, Immunosuppressed, Covid-19, SARS-COV-2, SARS-COV-2 Infection, Breakthrough InfectionView official trial listing → -
Terminated NCT NCT05022329
COVID-19 Vaccine Boosters in Patients With CKD
Not yet reported, Not yet reported Sunnybrook Health Sciences Centre 273 participants Est. completion 2022-11-15 3 sites Stand-aloneChronic kidney disease Other conditions: COVID-19View official trial listing → -
Completed NCT NCT05022472
Project 2VIDA! COVID-19 Vaccine Intervention Delivery for Adults in Southern California
Not yet reported Britt Skaathun 1051 participants Est. completion 2024-03-29 6 sites Stand-aloneOther conditions: Vaccine Refusal, Covid19View official trial listing → -
Completed NCT NCT05027464
Developing and Testing a COVID-19 Vaccination Acceptance Intervention
Not yet reported VA Office of Research and Development 338718 participants Est. completion 2024-09-30 2 sites Stand-aloneOther conditions: COVID-19 VaccinationView official trial listing → -
Completed NCT NCT05028361
Simultaneous mRNA COVID-19 and IIV4 Vaccination Study
Not yet reported Duke University 348 participants Est. completion 2023-06-15 3 sitesOther conditions: Quality of Life, Injection Site Reaction, Adverse Drug Event, Systemic ReactionView official trial listing → -
Active, not recruiting NCT NCT05032976
Korea Comirnaty Post-marketing Surveillance
Pfizer 12000 participants Est. completion 2027-01-24 1 siteOther conditions: COVID-19, Vaccines, Adverse Effects, SARS-CoV-2, SafetyView official trial listing → -
Status unknown NCT NCT05033834
Covid-19 Infection in After Vaccination
Assiut University 100 participants Est. completion 2022-12-31 3 sitesOther conditions: Covid19View official trial listing → -
Status unknown NCT NCT05033847
Clinical Trial on Sequential Immunization of Recombinant COVID-19 Vaccine (CHO Cells) and Inactivated COVID-19 Vaccine (Vero Cells) in Population Aged 18 Years and Above
Not yet reported National Vaccine and Serum Institute, China 1800 participants Est. completion 2024-01 1 site Stand-aloneOther conditions: COVID-19 Pneumonia, Coronavirus InfectionsView official trial listing → -
Withdrawn NCT NCT05035238
Evaluation of the Efficacy, Safety and Immunogenicity of Inactivated COVID 19 Vaccine(TURKOVAC) in Healthy Population of 18 and 64 Years of Age (Both Inclusive):a Randomized, Double-blind, Phase IIb Clinical Trial
Not yet reported Health Institutes of Turkey Est. completion 2021-10-01 1 siteOther conditions: Covid19View official trial listing → -
Terminated NCT NCT05037266
Cohort Assessing the Immunogenicity and the Safety of the COVID-19 Vaccine Janssen in Healthy Volunteers Based on 2 Age Groups: 65 Years or Older - 55 to 65 Years. Covicompare-Janssen
Not yet reported Centre Hospitalier Universitaire de Saint Etienne 27 participants Est. completion 2024-01-29 10 sites Stand-aloneOther conditions: Healthy VolunteersView official trial listing → -
Status unknown NCT NCT05043129
Safety and Immune Response of COVID-19 Vaccination in Patients With HIV Infection
The Second Affiliated Hospital of Chongqing Medical University 200 participants Est. completion 2022-09-04 1 siteOther conditions: HIV Infections, Covid19View official trial listing → -
Status unknown NCT NCT05043246
Safety and Immune Response of COVID-19 Vaccination in Patients With Basic Disease
The Second Affiliated Hospital of Chongqing Medical University 2300 participants Est. completion 2023-08-01 1 siteOther conditions: Diseases, Chronic, Covid19, Adverse Reaction to VaccineView official trial listing → -
Status unknown NCT NCT05043272
Safety and Immune Response of COVID-19 Vaccination in Overweight People With Excessive BMI
The Second Affiliated Hospital of Chongqing Medical University 450 participants Est. completion 2022-08-01 1 siteOther conditions: Covid19, OverweightView official trial listing → -
Status unknown NCT NCT05043311
The Safety and Immunogenicity of SCTV01C in Healthy Population Aged ≥18 Years Previously Vaccinated With mRNA COVID-19 Vaccine.
Not yet reported, Not yet reported Sinocelltech Ltd. 300 participants Est. completion 2023-01-01 1 siteOther conditions: COVID-19, SARS-CoV-2 InfectionView official trial listing → -
Completed NCT NCT05047718
Factors Influencing the COVID-19 Vaccine Immune Response According to Age and Presence or Not of a Past History of COVID-19
Not yet reported Centre Hospitalier Universitaire de Saint Etienne 54 participants Est. completion 2023-02-28 2 sites Stand-aloneOther conditions: Covid19View official trial listing → -
Completed NCT NCT05047822
Oxford/AstraZeneca COVID-19 Vaccine Effectiveness in England
AstraZeneca 18373714 participants Est. completion 2023-01-27 1 siteOther conditions: Covid-19 InfectionView official trial listing → -
Completed NCT NCT05048849
A Study to Evaluate the Safety, Tolerability, and Immunogenicity of COVID-19 Vaccine, CT-COV-21 Extension Study
Not yet reported Medigen Vaccine Biologics Corp. 274 participants Est. completion 2022-04-12 11 sitesOther conditions: Covid19 VaccineView official trial listing → -
Withdrawn NCT NCT05048940
Efficacy, Safety, and Immunogenicity of Vaccine Reimmunization With a Third Homologous Versus Heterologous Dose Against COVID-19 in Patients Undergoing Solid Organ Transplantation.
Not yet reported Instituto de Investigación Marqués de Valdecilla Est. completion 2021-09-01 1 site Stand-aloneOther conditions: Covid19View official trial listing → -
Completed NCT NCT05050474
Booster Immunization Study of Recombinant SARS-CoV-2 Fusion Protein Vaccine (V-01)
Not yet reported Livzon Pharmaceutical Group Inc. 43 participants Est. completion 2022-02-18 1 site Stand-aloneOther conditions: COVID19View official trial listing → -
Status unknown NCT NCT05051605
Immune Response to COVID-19 Vaccine in Recipients of Living Donor Liver Transplantation
Ain Shams University 50 participants Est. completion 2023-11-30 1 siteOther conditions: Liver TransplantView official trial listing → -
Completed NCT NCT05054621
Immunogenicity of COVID-19 Vaccine on Heterologous Schedule
Not yet reported Chang Gung Memorial Hospital 100 participants Est. completion 2022-08-31 1 siteOther conditions: Covid-19, Vaccine, Immunogenicity, Reactogenicity, HealthyView official trial listing → -
Completed NCT NCT05057182
Third Dose of mRNA Vaccination to Boost COVID-19 Immunity (mBoost Study)
Not yet reported The University of Hong Kong 300 participants Est. completion 2024-12-31 1 siteOther conditions: COVID 19 VaccineView official trial listing → -
Terminated NCT NCT05057897
A Study of AZD1222, a Vaccine for the Prevention of COVID-19 in Immunocompromised Adults
Not yet reported AstraZeneca 34 participants Est. completion 2023-04-19 4 sitesOther conditions: COVID-19, SARS-CoV-2View official trial listing → -
Status unknown NCT NCT05059106
EFFECTIVENESS, SAFETY AND IMMUNOGENICITY OF THE HALF DOSE OF THE VACCINE ChadOx1 nCoV-19 (AZD1222) for COVID-19
Not yet reported, Not yet reported Federal University of Espirito Santo 29637 participants Est. completion 2022-10-30 1 siteOther conditions: SARS-CoV-2View official trial listing → -
Completed NCT NCT05062525
Immune Response to COVID-19 Vaccine in Immunotherapy (IO) and Non-IO Treated Cancer Patients
University Health Network, Toronto 53 participants Est. completion 2021-09-28 1 siteOther conditions: COVID-19, CancerView official trial listing → -
Completed NCT NCT05067894
Safety and Immunogenicity of SARS-CoV-2 Protein Subunit Recombinant Vaccine
Not yet reported PT Bio Farma 54 participants Est. completion 2022-08-06 1 siteOther conditions: Covid19View official trial listing → -
Status unknown NCT NCT05067959
Covid-19 Vaccine Responses in Patients With Inflammatory Bowel Diseases
Rabin Medical Center 284 participants Est. completion 2022-03 1 siteOther conditions: IBD, Covid19View official trial listing → -
Status unknown NCT NCT05069129
Clinical Trial on Sequential Immunization of Recombinant COVID-19 Vaccine (CHO Cells,NVSI-06-08) and Inactivated COVID-19 Vaccine (Vero Cells) in Population Aged 18 Years and Above
Not yet reported, Not yet reported National Vaccine and Serum Institute, China 1848 participants Est. completion 2024-02 1 site Stand-aloneOther conditions: COVID-19 Pneumonia, Coronavirus InfectionsView official trial listing → -
Completed NCT NCT05074706
Evaluation of the Immune Response to Sars-Covid-19 Vaccines in Haematological Patients: Prospective Single Center Study
University of Milano Bicocca 700 participants Est. completion 2022-06-15 1 siteOther conditions: Hematologic DiseasesView official trial listing → -
Status unknown NCT NCT05075044
Immunogenicity and Safety of an Inactivated COVID-19 Vaccine in People Aged ≥18 Years With HIV Infected
Not yet reported China National Biotec Group Company Limited 400 participants Est. completion 2022-12-30 1 site Stand-aloneOther conditions: HIV Infections, COVID-19View official trial listing → -
Status unknown NCT NCT05075057
Immunogenicity and Safety of an Inactivated COVID-19 Vaccine in Patients Aged ≥60 Years With Chronic Bronchitis and COPD
Not yet reported China National Biotec Group Company Limited 400 participants Est. completion 2022-06-30 1 site Stand-aloneOther conditions: COVID-19, Chronic Bronchitis, CopdView official trial listing → -
Status unknown NCT NCT05075083
Immunogenicity and Safety of an Inactivated COVID-19 Vaccine in Elderly People With Chronic Bronchitis and COPD
Not yet reported China National Biotec Group Company Limited 400 participants Est. completion 2022-06-30 1 site Stand-aloneOther conditions: COVID-19, Chronic Bronchitis, COPDView official trial listing → -
Completed NCT NCT05076227
Effect of Different SARS-CoV-2 Vaccine Schedules and Vaccination Intervals on Reactogenicity and Humoral Immunogenicity
Serge Thal 1206 participants Est. completion 2022-03-27 1 siteOther conditions: SARS-CoV2 Infection, Immunisation Reaction, Antibody Hypersensitivity, ToleranceView official trial listing → -
Completed NCT NCT05080218
COVID-19 VaccinE Response in Rheumatology Patients
Not yet reported Jeffrey Curtis 841 participants Est. completion 2024-05-28 8 sitesOther conditions: Rheumatoid Arthritis, Psoriatic Arthritis, SpondylarthritisView official trial listing → -
Completed NCT NCT05083065
Evaluation of Menstrual Irregularities and Abnormal Uterine Bleeding After Covid-19 Vaccine
Università degli Studi dell'Insubria 369 participants Est. completion 2021-12-30 1 siteOther conditions: COVID-19, Vaccine, Menstrual Irregularity, Menopausal BleedingView official trial listing → -
Status unknown NCT NCT05087368
Immunogenicity and Safety of Heterologous and Homologous Boosting With ChAdOx1-S and CoronaVac or a Formulation of SCB-2019 (COVID-19)
Not yet reported D'Or Institute for Research and Education 520 participants Est. completion 2022-04-01 3 sites Stand-aloneOther conditions: Covid19View official trial listing → -
Completed NCT NCT05091307
A Study of Ad26.COV2.S and Influenza Vaccines in Healthy Adults
Not yet reported Janssen Vaccines & Prevention B.V. 861 participants Est. completion 2022-11-15 31 sitesOther conditions: COVID-19 PreventionView official trial listing → -
Completed NCT NCT05094609
Phase 1 Trial of ChAd68 and Ad5 Adenovirus COVID-19 Vaccines Delivered by Aerosol
Not yet reported McMaster University 36 participants Est. completion 2025-01-31 1 siteOther conditions: COVID-19, SARS-CoV2 InfectionView official trial listing → -
Completed NCT NCT05096091
International Study on COVID-19 Vaccine to Assess Immunogenicity, Reactogenicity and Efficacy (InVITE)
National Institute of Allergy and Infectious Diseases (NIAID) 5399 participants Est. completion 2025-08-19 11 sitesOther conditions: COVID-19View official trial listing → -
Completed NCT NCT05096260
Getting to Yes, Michigan! (G2YMI)
Not yet reported University of Michigan 1180 participants Est. completion 2025-09-30 1 site Stand-aloneOther conditions: COVID-19 Vaccines, COVID-19 PandemicView official trial listing → -
Completed NCT NCT05096832
Recombinant SARS-CoV-2 Fusion Protein Vaccine (V-01) Booster Study
Not yet reported Livzon Pharmaceutical Group Inc. 10381 participants Est. completion 2023-04-14 18 sites Stand-aloneOther conditions: COVID-19 PandemicView official trial listing → -
Status unknown NCT NCT05096845
Recombinant SARS-CoV-2 Fusion Protein Vaccine (V-01) Phase III
Not yet reported Livzon Pharmaceutical Group Inc. 22500 participants Est. completion 2023-06-14 25 sites Stand-aloneOther conditions: COVID-19 PandemicView official trial listing → -
Completed NCT NCT05099497
Supporting Audit and Feedback to Encourage Vaccine Uptake
Not yet reported Women's College Hospital 600 participants Est. completion 2022-11-15 1 site Stand-aloneOther conditions: Covid19 Vaccination, Vaccine UptakeView official trial listing → -
Completed NCT NCT05104385
Hacettepe University COVID-19 Vaccinated's Health Cohort- Students of Health Sciences
Hacettepe University 1223 participants Est. completion 2023-12-07 1 siteOther conditions: COVID-19 Pandemic, SARS-CoV2 Infection, Immunization; Infection, HealthView official trial listing → -
Status unknown NCT NCT05104437
Evaluation of Immunogenicity, Safety and Antibody Persistence of COVID-19 Booster Vaccine (Produced in Wuhan) in Patients With Hypertension and/or Diabetes
Not yet reported China National Biotec Group Company Limited 1440 participants Est. completion 2022-12 3 sites Stand-aloneOther conditions: COVID-19 PneumoniaView official trial listing → -
Completed NCT NCT05107271
Evaluation of Long Haul COVID-19 and Vaccine Immunogenicity in Patients With Liver Disease
Post Graduate Institute of Medical Education and Research, Chandigarh 252 participants Est. completion 2024-03-15 1 siteOther conditions: COVID-19, Chronic Liver Failure, Cirrhosis, Liver, Portal Hypertension, Liver Transplant DisorderView official trial listing → -
Completed NCT NCT05107375
Clinical Study of Recombinant Novel Coronavirus(COVID-19) Vaccine (CHO Cell) Combined With Influenza Vaccine
Not yet reported Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. 299 participants Est. completion 2022-03-04 1 siteOther conditions: Coronavirus Disease 2019View official trial listing → -
Completed NCT NCT05107557
Immunogenicity And Safety of COVID-19 Vaccine , Inactivated Co -Administration With EV71 Vaccine (Vero Cell)
Not yet reported Sinovac Biotech Co., Ltd 520 participants Est. completion 2022-07-14 2 sites Stand-aloneOther conditions: COVID-19View official trial listing → -
Status unknown NCT NCT05109559
Ad26.COV2.S as a Heterologous Booster in Adults After Single- or Two-Dose of Inactivated COVID-19 Vaccine
Not yet reported, Not yet reported Mahidol University 690 participants Est. completion 2024-12 1 site Stand-aloneOther conditions: SARS-CoV-2 InfectionView official trial listing → -
Completed NCT NCT05109598
Clinical Trial of Immunogenicity Bridging of a Recombinant New Coronavirus(COVID-19) Vaccine (CHO Cell)
Not yet reported Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. 400 participants Est. completion 2023-04-06 1 siteOther conditions: COVID-19View official trial listing → -
Completed NCT NCT05112848
A Study to Evaluate Safety and Immunogenicity of a COVID-19 Vaccine in People Living With HIV at Risk for SARS-CoV-2 (COVID-19)
Not yet reported Novavax 384 participants Est. completion 2022-11-30 7 sitesOther conditions: SARS-CoV-2 InfectionView official trial listing → -
Completed NCT NCT05113472
Adverse Reactions Following COVID-19 Vaccination Among Ecuadorian Healthcare Workers
Respiralab 1291 participants Est. completion 2021-05-31 1 siteOther conditions: Adverse Drug EventView official trial listing → -
Completed NCT NCT05119855
Safety and Immunogenicity of 9-valent Human Papillomavirus (9vHPV) Vaccine Coadministered With Messenger Ribonucleic Acid (mRNA)-1273 Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) (COVID-19) Vaccine (V503-076)
Not yet reported Merck Sharp & Dohme LLC 165 participants Est. completion 2023-12-12 38 sitesOther conditions: Papillomavirus Infections, Coronavirus Disease (COVID-19)View official trial listing → -
Completed NCT NCT05121662
COVID-19 Vaccine Biomarker Study in Multiple Sclerosis
Columbia University 154 participants Est. completion 2025-02-13 1 siteOther conditions: Multiple Sclerosis, COVID-19View official trial listing → -
Status unknown NCT NCT05124171
Immunogenicity and Reactogenicity Following a Booster Dose of COVID-19 mRNA Vaccine (Pfizer-BioNtech) and Two Adjuvanted Sub-unit Vaccines (SP/GSK) Administered in Adults Who Received 2 Doses of Pfizer-BioNTech mRNA Vaccine as a Primary Vaccination
Not yet reported Assistance Publique - Hôpitaux de Paris 247 participants Est. completion 2022-12 1 siteOther conditions: COVID-19, Vaccine ReactionView official trial listing → -
Completed NCT NCT05124223
Analysis of Cardiac Damage Post Infection With SARS-CoV-2 and Post Vaccination Against COVID-19
Sebastian Kelle 131 participants Est. completion 2021-08-31 1 siteOther conditions: Myocarditis AcuteView official trial listing → -
Withdrawn NCT NCT05124561
Study to Evaluate the inHaled Recombinant COVID-19 Vaccine (Adenovirus Type 5 Vector) On the Protective-Efficacy in Adults (SeiHOPE)
Not yet reported CanSino Biologics Inc. Est. completion 2022-08-20 Stand-aloneOther conditions: COVID-19View official trial listing → -
Status unknown NCT NCT05126550
The Immunogenicity, Safety, and Effectiveness of the COVID-19 Inactivated Vaccine
PT. Kimia Farma (Persero) Tbk 435 participants Est. completion 2022-11-30 4 sitesOther conditions: COVID-19View official trial listing → -
Status unknown NCT NCT05128643
Clinical Study on the Immune Program of Recombinant Novel Coronavirus(COVID-19) Vaccine (CHO Cell)
Not yet reported Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. 300 participants Est. completion 2022-10-12 1 siteOther conditions: Coronavirus Disease 2019View official trial listing → -
Status unknown NCT NCT05128721
Evaluation of Inactivated Vaccine in Healthy Adults Against Coronavirus Disease of 2019 (COVID-19)
Not yet reported National Research Centre, Egypt 72 participants Est. completion 2023-05-23 1 siteOther conditions: COVID-19, Vaccine Reaction, Vaccine Adverse ReactionView official trial listing → -
Completed NCT NCT05132907
Safety and Immunogenicity of HDT-301 Targeting a SARS-CoV-2 Variant Spike Protein
Not yet reported HDT Bio 48 participants Est. completion 2024-05-30 1 siteOther conditions: SARS-CoV2 InfectionView official trial listing → -
Status unknown NCT NCT05133609
COVID-19 VACCINE SAFETY AND EFFECTIVENESS
Not yet reported, Not yet reported Federal University of Espirito Santo 550 participants Est. completion 2023-12-30 1 siteOther conditions: SARS-CoV-2 InfectionView official trial listing → -
Completed NCT NCT05135585
Evaluation of the Post-vaccination Immune Response to COVID-19 in the New Caledonian Population
Not yet reported Institut Pasteur 680 participants Est. completion 2022-09-17 3 sitesOther conditions: SARS-CoV-2 Acute Respiratory DiseaseView official trial listing → -
Status unknown NCT NCT05137444
Phase Ⅱ and Ⅲ Trial of a SARS-CoV-2 Vaccine LYB001
Not yet reported, Not yet reported Yantai Patronus Biotech Co., Ltd. 1900 participants Est. completion 2023-05Other conditions: COVID-19View official trial listing → -
Completed NCT NCT05142319
Efficacy of Different COVID-19 Vaccine Combinations in Inducing Long-term Humoral Immunity [PRIBIVAC]
Not yet reported Tan Tock Seng Hospital 326 participants Est. completion 2024-05-07 1 siteOther conditions: COVID-19View official trial listing → -
Terminated NCT NCT05142332
PROmotion of COvid-19 VA(X)Ccination in the Emergency Department - PROCOVAXED
Not yet reported University of California, San Francisco 541 participants Est. completion 2022-08-30 7 sites Stand-aloneOther conditions: Covid-19 Vaccine, Vaccine HesitancyView official trial listing → -
Terminated NCT NCT05142501
Observation of the Immune Response After COVID-19 Additional Vaccine Doses in Chronic Patients in Hemodialysis Therapy
Fresenius Medical Care Deutschland GmbH 23 participants Est. completion 2022-09-02 11 sitesChronic kidney disease Other conditions: COVID-19, HemodialysisView official trial listing → -
Completed NCT NCT05144139
A Phase I/II Clinical Trial in Healthy People Aged 18 Years and Above
Not yet reported, Not yet reported Stemirna Therapeutics 480 participants Est. completion 2022-11-11 1 siteOther conditions: COVID-19 PandemicView official trial listing → -
Status unknown NCT NCT05148949
Study on Three Doses of an Inactivated COVID-19 Vaccine in Chinese Pulmonary Tuberculosis Patients
Not yet reported Jiangsu Province Centers for Disease Control and Prevention 240 participants Est. completion 2023-03-10 6 sitesOther conditions: COVID-19, Pulmonary TuberculosisView official trial listing → -
Completed NCT NCT05148962
Study of GRT-R910 COVID-19 Boost Vaccine in Healthy Volunteers
Not yet reported Gritstone bio, Inc. 45 participants Est. completion 2023-05-26 3 sites Stand-aloneOther conditions: COVID-19View official trial listing → -
Withdrawn NCT NCT05155982
A Clinical Trial of COVAC-1, a COVID-19 Vaccine, in Generally Healthy Adults
Not yet reported University of Saskatchewan Est. completion 2023-10Other conditions: Severe Acute Respiratory Syndrome Coronavirus 2View official trial listing → -
Withdrawn NCT NCT05156632
Efficacy,Immunogenicity and Safety of COVID-19 Vaccine , Inactivated Booster Dose in Adults Aged 18 Years and Above
Not yet reported Sinovac Research and Development Co., Ltd. Est. completion 2023-02-20 Stand-aloneOther conditions: COVID-19View official trial listing → -
Completed NCT NCT05157191
Safety of Pediatric COVID-19 Vaccination
Duke University 299 participants Est. completion 2023-10-27 5 sitesOther conditions: Pain, Injection Site Reaction, Adverse Drug EventView official trial listing → -
Active, not recruiting NCT NCT05160636
A Study to Look at the Health Outcomes of Patients With COVID-19 and Influenza
Pfizer 999 participants Est. completion 2027-01-31 1 siteOther conditions: COVID-19, Coronavirus Disease 2019, InfluenzaView official trial listing → -
Status unknown NCT NCT05162482
Combination Assessment Trial of COVID-19 Vaccines (COMBAT-COVID)
Not yet reported Aga Khan University Hospital, Pakistan 1680 participants Est. completion 2024-06-30 3 sitesOther conditions: COVID 19 VaccineView official trial listing → -
Status unknown NCT NCT05163652
Clinical Study of the Third Dose Immunization Schedule of COVID-19 Inactivated Vaccine, (Vero Cells) Based on Different COVID-19 Inactivated Vaccine in Adults Aged 18 Years and Above
Not yet reported Chinese Academy of Medical Sciences 432 participants Est. completion 2022-10-30 1 siteOther conditions: SARS-CoV-2 InfectionView official trial listing → -
Completed NCT NCT05164016
Evaluating Immune Response to COVID-19 Vaccines in Patients With Cancer, Transplant or Cellular Therapy Recipients
St. Jude Children's Research Hospital 21 participants Est. completion 2026-04-09 3 sitesOther conditions: Cancer, Hematopoietic System--Cancer, Transplant-Related Cancer, Solid Tumor Malignancy, Hematologic Malignancy, Solid Organ Transplant, Hematopoietic Cell Transplant, Cellular TherapyView official trial listing → -
Status unknown NCT NCT05164731
Clinical Study of the Third Dose Immunization Schedule of COVID-19 Inactivated Vaccine, (Vero Cells) in Adults Aged 18 Years and Above
Not yet reported Chinese Academy of Medical Sciences 880 participants Est. completion 2022-10-30 1 siteOther conditions: SARS-CoV2 InfectionView official trial listing → -
Suspended NCT NCT05165732
Safety and Immunogenicity Study of Booster Vaccination With COVID-19 Vaccine (Vero Cell),Inactivated From Different Manufactures for Prevention of COVID-19
Not yet reported Sinovac Research and Development Co., Ltd. 480 participants Est. completion 2023-08-20 1 site Stand-aloneOther conditions: COVID-19View official trial listing → -
Completed NCT NCT05165966
Safety and Immunogenicity Study of Booster Vaccination in Different Doses of COVID-19 Vaccine (Vero Cell),Inactivated for Prevention of COVID-19
Not yet reported Sinovac Life Sciences Co., Ltd. 340 participants Est. completion 2022-07-01 1 site Stand-aloneOther conditions: COVID-19View official trial listing → -
Completed NCT NCT05168709
Investigating COVID-19 Vaccine Immunity in Children in the Melbourne Infant Study of BCG for Allergy and Infection Reduction
Not yet reported Murdoch Childrens Research Institute 51 participants Est. completion 2022-09-29 1 site Stand-aloneOther conditions: COVID-19, Vaccine Reaction, Immunization; InfectionView official trial listing → -
Completed NCT NCT05168800
CONFIDENT: Supporting Long-term Care Workers During COVID-19
Not yet reported Dartmouth-Hitchcock Medical Center 2634 participants Est. completion 2023-09-20 1 site Stand-aloneOther conditions: COVID-19View official trial listing → -
Terminated NCT NCT05169008
A Study to Evaluate the Safety and Immunogenicity of Ad5-nCoV and Ad5-nCoV-IH in CoronaVac Immunized Children and Adolescents
Not yet reported CanSino Biologics Inc. 91 participants Est. completion 2023-01-13 2 sites Stand-aloneOther conditions: COVID-19View official trial listing → -
Active, not recruiting NCT NCT05172011
Understanding the Long-term Impact of COVID on Children and Families
NYU Langone Health 15028 participants Est. completion 2029-09-30 65 sitesOther conditions: SARS-CoV-2 InfectionView official trial listing → -
Completed NCT NCT05175742
PTX-COVID19-B, an mRNA Humoral Vaccine, Intended for Prevention of COVID-19 in a General Population. This Study is Designed to Demonstrate the Safety, Tolerability, and Immunogenicity of PTX-COVID19-B in Comparison to the Pfizer-BioNTech COVID-19 Vaccine.
Not yet reported Providence Therapeutics Holdings Inc. 565 participants Est. completion 2023-03-29 11 sitesOther conditions: Covid19 VaccineView official trial listing → -
Completed NCT NCT05178264
Transverse Myelitis Related to SARS-CoV-2 Vaccines
University Hospital, Caen 580 participants Est. completion 2021-12-10 1 siteOther conditions: Vaccine Adverse ReactionView official trial listing → -
Status unknown NCT NCT05185817
Effectiveness of COVID-19 Vaccine in Hematopoietic Stem Cell Transplant Patients
Not yet reported Tehran University of Medical Sciences 100 participants Est. completion 2023-07-01 1 siteOther conditions: Hematopoietic Stem Cell Transplantation (HSCT), COVID-19 Vaccines, Immune System ToleranceView official trial listing → -
Status unknown NCT NCT05191368
Safety and Immunogenicity of Sars-cov-2 Vaccine in Patients With Rheumatic Diseases
Yunnan University of Chinese Medicine 500 participants Est. completion 2022-06-01 1 siteOther conditions: Rheumatic DiseaseView official trial listing → -
Withdrawn NCT NCT05193279
Safety and Immunogenicity of SCB-2019 in Children <18 Years of Age
Not yet reported, Not yet reported Clover Biopharmaceuticals AUS Pty Est. completion 2022-12-15 2 sitesOther conditions: COVID-19View official trial listing → -
Completed NCT NCT05197153
A Study to Evaluate the Safety and Immunogenicity of Booster With AZD1222, mRNA-1273, or MVC-COV1901 Against COVID-19
Not yet reported Medigen Vaccine Biologics Corp. 804 participants Est. completion 2022-10-28 4 sitesOther conditions: COVID-19 VaccineView official trial listing → -
Completed NCT NCT05198336
Immunogenicity of an Inactivated COVID-19 Vaccine
Not yet reported Sinovac Research and Development Co., Ltd. 395 participants Est. completion 2022-12-30 1 site Stand-aloneOther conditions: COVID-19View official trial listing → -
Completed NCT NCT05204589
Heterologous Boost Immunization with an Aerosolised Ad5-nCoV After Two-dose Priming with an Inactivated SARS-CoV-2 Vaccine
Not yet reported Jiangsu Province Centers for Disease Control and Prevention 10285 participants Est. completion 2022-10-27 1 siteOther conditions: COVID-19View official trial listing → -
Completed NCT NCT05205746
Phase II Study of AVX/COVID-12 Vaccine in Subjects With Prior SARS-CoV-2 Immunity Evidence
Not yet reported Laboratorio Avi-Mex, S.A. de C.V. 158 participants Est. completion 2023-07-24 4 sitesOther conditions: SARS CoV 2 InfectionView official trial listing → -
Completed NCT NCT05209009
A Clinical Trial of COVAC-2 in Adults
Not yet reported University of Saskatchewan 150 participants Est. completion 2024-03-01 2 sitesOther conditions: Severe Acute Respiratory Syndrome Coronavirus 2View official trial listing → -
Completed NCT NCT05212974
COVID-19 Vaccine Hesitancy Among Nurses
National Taiwan University Hospital 4258 participants Est. completion 2022-05-19 1 siteOther conditions: COVID-19, Vaccine Hesitancy, Vaccination, NursesView official trial listing → -
Status unknown NCT NCT05213000
Adjuvant Effect of Physical Exercise on Immune Response to COVID-19 Vaccination and Interactions With Stress
Not yet reported Iowa State University 80 participants Est. completion 2026-09-30 1 site Stand-aloneOther conditions: ImmunizationView official trial listing → -
Terminated NCT NCT05216510
Assessment of Delayed-type Hypersensitivity Reactions to SARS-CoV-2 Peptide Antigens
Not yet reported Tonix Pharmaceuticals, Inc. 9 participants Est. completion 2022-09-17 1 siteOther conditions: Detection of Delayed-type Hypersensitivity Reactions to SARS-CoV-2 in Individuals Exposed to SARS-CoV-2View official trial listing → -
Terminated NCT NCT05220397
Janssen Ad26.CoV2.S Vaccine Booster in Kidney Transplant Recipients
Not yet reported Mark Stegall 468 participants Est. completion 2025-02-28 3 sitesOther conditions: Kidney Transplant RecipientView official trial listing → -
Status unknown NCT NCT05225285
Efficacy, Immunogenicity and Safety of Inactivated Vaccine (Coronavac) Against SARS-COV2 in Children and Adolescents
Not yet reported Federal University of Espirito Santo 1120 participants Est. completion 2023-03-21 1 siteOther conditions: COVID-19View official trial listing → -
Completed NCT NCT05226702
Clinical Trial to Study the COVAC-2 Booster Dose (for COVID-19) in Generally Healthy Adults.
Not yet reported University of Saskatchewan 60 participants Est. completion 2023-11-13 3 sitesOther conditions: Double Vaccinated for COVID-19 (For Phase 1 of the Study), Acute Respiratory Syndrome Coronavirus 2 (For Phase 2 Exploratory Group)View official trial listing → -
Active, not recruiting NCT NCT05228275
Evaluation of Immunologic Response Following COVID-19 Vaccination in Children, Adolescents, and Young Adults With Cancer
Children's Oncology Group 549 participants Est. completion 2028-03-31 72 sitesOther conditions: COVID-19 Infection, Hematopoietic and Lymphatic System Neoplasm, Malignant Solid NeoplasmView official trial listing → -
Completed NCT NCT05228912
Immunization of 7 Different Vaccines Against SARS-COV-2 Across 4 Countries.
Hospital Clinica Nova 1870 participants Est. completion 2022-10-30 1 siteOther conditions: Vaccine Adverse Reaction, COVID-19, Vaccine ReactionView official trial listing → -
Status unknown NCT NCT05230953
Fourth COVID-19 Vaccine Dose- mRNA1273
Not yet reported Sheba Medical Center 1000 participants Est. completion 2024-07-04 1 siteOther conditions: COVID-19 PandemicView official trial listing → -
Completed NCT NCT05231590
Immunogenicity and Safety of the SpikoGen COVID-19 Vaccine in Children Aged 5 to <12 Years and 12 to <18 Years Compared With Adults Aged 18 to 40 Years
Not yet reported Cinnagen 581 participants Est. completion 2022-09-30 1 siteOther conditions: COVID-19View official trial listing → -
Completed NCT NCT05233592
Glycemic Effects of the COVID-19 Booster Vaccine in Type 1 Diabetes
Johns Hopkins University 21 participants Est. completion 2023-04-04 1 siteOther conditions: Type 1 Diabetes, Diabetes Mellitus, Type 1View official trial listing → -
Completed NCT NCT05234333
COVID-19 Vaccines Associated Malaise
University Hospital, Caen 1534706 participants Est. completion 2022-01-26 1 siteOther conditions: Vaccine Adverse ReactionView official trial listing → -
Completed NCT NCT05236270
CATCH-UP Vaccines: Engaged Approaches to Testing in Community/Healthcare Settings for the Underserved (COVID-19)
Not yet reported University of Oklahoma 312 participants Est. completion 2023-08-26 1 site Stand-aloneOther conditions: COVID-19, Vaccine RefusalView official trial listing → -
Status unknown NCT NCT05238454
A Phase II Clinical Trial to Evaluate the Immunogenicity and Safety of SCTV01C in Population Aged ≥18 Years and Previously Fully Vaccinated With COVID-19 Vaccine
Not yet reported Sinocelltech Ltd. 600 participants Est. completion 2022-12-01Other conditions: COVID-19, SARS-CoV-2 InfectionView official trial listing → -
Status unknown NCT NCT05239832
Recombinant SARS-CoV-2 Fusion Protein Vaccine Booster Immunization Study to Evaluate the Safety and Immunogencity
Not yet reported Livzon Pharmaceutical Group Inc. 34 participants Est. completion 2022-08-05 1 site Stand-aloneOther conditions: COVID-19 PandemicView official trial listing → -
Completed NCT NCT05244356
Health Communication to Influence COVID-19 Vaccination Intent and Message Propagation
Not yet reported Clinical Research Centre, Malaysia 5784 participants Est. completion 2021-06-07 1 site Stand-aloneOther conditions: COVID-19, Respiratory Disease, Vaccine Refusal, Infectious Disease, Coronavirus Infections, Behavior, Health, Pneumonia, Respiratory Tract Infections, Lung Diseases, Pneumonia, ViralView official trial listing → -
Completed NCT NCT05252442
Association of the Risk for Thrombotic Thrombocytopenia Syndrome and Exposure To COVID-19 Vaccines
AstraZeneca 7641136 participants Est. completion 2023-07-11 1 siteOther conditions: Covid-19View official trial listing → -
Terminated NCT NCT05252910
Specimen Collection Study From Coronavirus Disease 2019 (COVID-19) Vaccinated Adults and Adolescents
Pharm-Olam, LLC 33 participants Est. completion 2022-03-04 32 sitesOther conditions: COVID-19View official trial listing → -
Status unknown NCT NCT05258669
Immuno-bridging and Broadening Study of a Whole, Inactivated COVID-19 Vaccine BBV152 in Healthy Adults
Not yet reported, Not yet reported Ocugen 400 participants Est. completion 2023-10-31 10 sitesOther conditions: COVID-19View official trial listing → -
Completed NCT NCT05265065
Evaluation of Full Versus Fractional Dose of COVID-19 Vaccine Given as a Booster for the Prevention of COVID-19 in Adults in Mongolia.
Not yet reported Murdoch Childrens Research Institute 601 participants Est. completion 2024-11-06 1 site Stand-aloneOther conditions: COVID-19View official trial listing → -
Completed NCT NCT05268185
The BOOSTED (Booster Options Or Switching Tested for Effectiveness and Downsides Study) Trial (COVID-19)
Not yet reported University of California, San Francisco 301 participants Est. completion 2023-01-18 1 siteOther conditions: COVID-19, Vaccine Reaction, COVID-19 PandemicView official trial listing → -
Completed NCT NCT05268679
Covid-19 Vaccine Response in Heart Transplant Recipients
Assistance Publique - Hôpitaux de Paris 190 participants Est. completion 2022-11-30 1 siteOther conditions: Heart Transplantation, COVID-19 Virus Infection, COVID-19 VaccineView official trial listing → -
Status unknown NCT NCT05279365
PROSPECTIVE OPEN LABEL CLINICAL TRIAL TO ADMINISTER A BOOSTER DOSE OF PFIZER/BIONTECH OR MODERNA COVID-19 VACCINE IN HIGH-RISK INDIVIDUALS
Not yet reported, Not yet reported DHR Health Institute for Research and Development 1000 participants Est. completion 2023-08-31 4 sitesOther conditions: SARS CoV 2 Infection, COVID-19View official trial listing → -
Terminated NCT NCT05280158
High-Dose Moderna mRNA-1273 Booster Study for Lung Transplant Recipients
Not yet reported, Not yet reported University of California, Los Angeles 19 participants Est. completion 2023-02-27 1 site Stand-aloneOther conditions: Lung Transplant Recipient, SARS-CoV-2, ImmunosuppressionView official trial listing → -
Completed NCT NCT05285384
Immunogenicity and Safety of a Booster Dose of the SpikoGen Vaccine in Kidney Transplant Recipients After Two Doses of Sinopharm Vaccine
Not yet reported Cinnagen 43 participants Est. completion 2022-03-30 1 site Stand-aloneOther conditions: COVID-19View official trial listing → -
Status unknown NCT NCT05293665
Platform Trial to Compare Homologous Boost of Authorized COVID-19 Vaccines and Heterologous Boost With UB-612 Vaccine
Not yet reported Vaxxinity, Inc. 944 participants Est. completion 2023-09 7 sitesOther conditions: COVID-19 VaccinesView official trial listing → -
Withdrawn NCT NCT05298644
COVID-19 Paediatric VLA2001-321 Study
Not yet reported, Not yet reported Valneva Austria GmbH Est. completion 2025-08-30Other conditions: SARS-CoV-2 InfectionView official trial listing → -
Completed NCT NCT05303584
Heterologous Boost Immunization with Ad5-nCoV After Three-dose Priming with an Inactivated SARS-CoV-2 Vaccine
Not yet reported Jiangsu Province Centers for Disease Control and Prevention 362 participants Est. completion 2023-05-31 1 site Stand-aloneOther conditions: COVID-19View official trial listing → -
Completed NCT NCT05305573
Assessing the Immunogenicity and Safety of a HIPRA's Candidate Booster Vaccination in Adults Fully Vaccinated With Adenovirus Vaccine Against COVID-19.
Not yet reported Hipra Scientific, S.L.U 26 participants Est. completion 2023-11-14 7 sites Stand-aloneOther conditions: SARS-CoV-2 InfectionView official trial listing → -
Completed NCT NCT05310084
Safety and Immunogenicity of BNT162b2 Coadministered With SIIV in Adults 18 Through 64 Years of Age
Not yet reported BioNTech SE 1134 participants Est. completion 2022-10-05 26 sitesOther conditions: SARS-CoV-2 Infection, COVID-19View official trial listing → -
Completed NCT NCT05313035
Safety and Immunogenicity Study of COVID-19 Protein Subunit Recombinant Vaccine
Not yet reported, Not yet reported PT Bio Farma 360 participants Est. completion 2023-02-28 3 sitesOther conditions: COVID-19View official trial listing → -
Completed NCT NCT05313074
SARS-CoV-2 Specific Immune Response After COVID-19 Vaccination in Cancer Patients
Not yet reported National Cancer Institute, Thailand 311 participants Est. completion 2022-02-25 1 siteOther conditions: COVID-19, CancerView official trial listing → -
Completed NCT NCT05313087
COVID-19 Vaccine Response in Chronic Respiratory Conditions
National Jewish Health 360 participants Est. completion 2023-12-30 1 siteOther conditions: SARS-CoV InfectionView official trial listing → -
Completed NCT NCT05313646
Clinical Evaluation for Batch Consistency of Ad5-nCoV in Chinese Healthy Adults
Not yet reported Jiangsu Province Centers for Disease Control and Prevention 1050 participants Est. completion 2021-09-08 1 siteOther conditions: COVID-19View official trial listing → -
Status unknown NCT NCT05315856
Reactogenicity, Immunogenicity and Inflammatory Response by New COVID-19 Vaccine Platforms
Korea University Guro Hospital 120 participants Est. completion 2022-12-31 3 sitesOther conditions: COVID-19 Vaccination, Inflammation, Vaccine Immune Response, Vaccine Adverse ReactionView official trial listing → -
Active, not recruiting NCT NCT05321407
COVID-19 Vaccine Responses in PIDD Subjects
Duke University 100 participants Est. completion 2026-07-31 3 sitesOther conditions: X-linked Agammaglobulinemia, XLA, Primary Immune Deficiency, CVID, Common Variable Immunodeficiency, Primary Antibody Deficiencies, Secondary HypogammaglobulinemiaView official trial listing → -
Status unknown NCT NCT05323461
A Study to Evaluate the Immunogenicity and Safety of Two Recombinant Protein COVID-19 Vaccines in Population Aged ≥18 Years as Booster Vaccines
Not yet reported Sinocelltech Ltd. 1800 participants Est. completion 2023-05-01 1 siteOther conditions: COVID-19, SARS-CoV-2 InfectionView official trial listing → -
Status unknown NCT NCT05324319
Homologous vs Heterologous Third Vaccination in Kidney Transplant Recipients Kidney Transplant Recipients
Not yet reported Medical University of Vienna 200 participants Est. completion 2022-12-31 1 siteOther conditions: COVID-19View official trial listing → -
Status unknown NCT NCT05329038
Immunogenicity,Safety and Cross - Immune Response With Mutant Strains of a Third Dose of an Inactivated COVID-19 Vaccine
Not yet reported Sinovac Life Sciences Co., Ltd. 180 participants Est. completion 2024-02-20 1 site Stand-aloneOther conditions: COVID-19View official trial listing → -
Status unknown NCT NCT05329051
A Study to Evaluate the Immunogenicity and Safety of a Recombinant Protein COVID-19 Vaccine in Population Aged ≥18 Years
Not yet reported Sinocelltech Ltd. 400 participants Est. completion 2023-03-01Other conditions: SARS-CoV-2 Infection, COVID-19View official trial listing → -
Status unknown NCT NCT05329064
Determining Reactogenicity and Immunogenicity of Delayed COVID-19 Vaccine Schedule in Children
Not yet reported KK Women's and Children's Hospital 150 participants Est. completion 2023-12-31 1 siteOther conditions: Vaccine Reaction, COVID-19, Children, OnlyView official trial listing → -
Completed NCT NCT05329220
ABNCoV2 Vaccine in Adult Subjects Previously Vaccinated for SARS-CoV-2
Not yet reported Bavarian Nordic 4205 participants Est. completion 2023-10-05 57 sitesOther conditions: COVID-19 DiseaseView official trial listing → -
Status unknown NCT NCT05338177
Pilot Trial on Immunosuppression Modulation to Increase SARS-CoV-2 Vaccine Response in Kidney Transplant Recipients
Not yet reported Medical University of Vienna 40 participants Est. completion 2022-11-14 1 siteOther conditions: COVID-19View official trial listing → -
Completed NCT NCT05352867
Clinical Trial of SARS-CoV-2 mRNA Vaccine in Chinese People
Not yet reported AIM Vaccine Co., Ltd. 420 participants Est. completion 2023-06-21 2 sitesOther conditions: SARS-CoV-2View official trial listing → -
Completed NCT NCT05354024
Phase II/III Randomized Clinical Trial of Booster Dose of COVID-19 (Recombinant, Inactivated) Vaccine
Not yet reported, Not yet reported Butantan Institute 4400 participants Est. completion 2024-09-25 6 sitesOther conditions: Coronavirus Infections, HealthyView official trial listing → -
Completed NCT NCT05364242
VLA2001 Booster in Adult Participants After Priming With mRNA COVID-19 Vaccine and/or Natural SARS-CoV-2 Infection
Not yet reported, Not yet reported Valneva Austria GmbH 178 participants Est. completion 2023-05-22 4 sitesOther conditions: SARS-CoV-2 InfectionView official trial listing → -
Completed NCT NCT05366322
A Study to Compare mRNA-1273 Versus BNT162b2 COVID-19 Vaccines Among Immunocompromised Adults
ModernaTX, Inc. 124879 participants Est. completion 2022-03-21 1 siteOther conditions: SARS-CoV-2View official trial listing → -
Terminated NCT NCT05370040
THEMBA II T-Cell Vaccine: Vaccination With saRNA COVID-19 Vaccines
Not yet reported, Not yet reported ImmunityBio, Inc. 60 participants Est. completion 2024-03-11 1 siteOther conditions: COVID-19View official trial listing → -
Status unknown NCT NCT05373030
Sequential Immunization With Recombinant Adenovirus Type-5-vectored COVID-19 Vaccine in Health Adults Based on 3 Doses Inactivated COVID-19 Vaccine
Not yet reported Zhejiang Provincial Center for Disease Control and Prevention 200 participants Est. completion 2023-06-30 1 site Stand-aloneOther conditions: Immunogenicity and Safety of a Recombinant Adenovirus Type-5-vectored COVID-19 Vaccine Using for Sequential ImmunizationView official trial listing → -
Completed NCT NCT05373472
Phase II Clinical Trial of COVID-19 mRNA Vaccine in Adults Aged 18 Years and Older
Not yet reported CanSino Biologics Inc. 150 participants Est. completion 2022-09-21 3 sitesOther conditions: COVID-19View official trial listing → -
Completed NCT NCT05373485
Phase I Clinical Trial of COVID-19 mRNA Vaccine in Adults Aged 18 Years and Older
Not yet reported CanSino Biologics Inc. 43 participants Est. completion 2022-08-08 3 sitesOther conditions: COVID-19View official trial listing → -
Status unknown NCT NCT05374954
Study on Sequential Immunization of Omicron Inactivated COVID-19 Vaccine and Prototype Inactivated COVID-19 Vaccine in Population Aged 18 Years Old and Above
Not yet reported China National Biotec Group Company Limited 4200 participants Est. completion 2023-11-10 10 sites Stand-aloneOther conditions: COVID-19View official trial listing → -
Completed NCT NCT05375838
A Safety, Reactogenicity, and Immunogenicity Study of mRNA-1073 (COVID-19/Influenza) Vaccine in Adults 18 to 75 Years Old
Not yet reported, Not yet reported ModernaTX, Inc. 550 participants Est. completion 2022-12-29 14 sitesOther conditions: SARS-CoV-2, InfluenzaView official trial listing → -
Completed NCT NCT05383560
Safety and Immunogenicity of Omicron Variant-Matched Vaccine Booster in Adults
Not yet reported Sheba Medical Center 179 participants Est. completion 2024-01-31 1 siteOther conditions: COVID-19 Pandemic, Immunogenicity, SARS CoV 2 Infection, COVID-19View official trial listing → -
Completed NCT NCT05386355
Improving Pediatric COVID-19 Vaccine Uptake Using an mHealth Tool
Not yet reported IDeA States Pediatric Clinical Trials Network 1934 participants Est. completion 2023-09-25 15 sites Stand-aloneOther conditions: COVID-19 Vaccines, Telemedicine, Vaccine Hesitancy, Pediatric ALLView official trial listing → -
Status unknown NCT NCT05387252
Glucoside- and Rutinoside-rich Crude Material for Relieving Side Effects of COVID-19 Vaccines
Not yet reported Taipei Medical University 93 participants Est. completion 2023-05-31Other conditions: Vaccine Adverse Reaction, Side-EffectView official trial listing → -
Withdrawn NCT NCT05387317
Evaluation of COVID-19 Vaccines Given as a Booster in Healthy Adults in Indonesia (MIACoV Indonesia)
Not yet reported Murdoch Childrens Research Institute Est. completion 2025-10 3 sites Stand-aloneOther conditions: COVID-19View official trial listing → -
Active, not recruiting NCT NCT05389319
A Study to Assess the Safety and Immunogenicity of a COVID-19 Vaccine Booster in Healthy Adults
Not yet reported University Hospital Tuebingen 96 participants Est. completion 2026-12-31 2 sitesOther conditions: COVID-19View official trial listing → -
Status unknown NCT NCT05394012
A Phase 1a Trial to Evaluate the Safety and Immunogenicity of a SARS-CoV-2 mRNA Chimera Vaccine Against COVID-19
Not yet reported Walvax Biotechnology Co., Ltd. 120 participants Est. completion 2023-06Other conditions: COVID-19View official trial listing → -
Status unknown NCT NCT05396573
A Phase 1b Trial to Evaluate the Safety and Immunogenicity of a SARS-CoV-2 mRNA Chimera Vaccine Against COVID-19
Not yet reported Walvax Biotechnology Co., Ltd. 120 participants Est. completion 2023-07Other conditions: COVID-19View official trial listing → -
Completed NCT NCT05397223
A Study of Modified mRNA Vaccines in Healthy Adults
Not yet reported ModernaTX, Inc. 308 participants Est. completion 2026-02-27 8 sitesOther conditions: SARS-CoV-2, Seasonal Influenza, Respiratory Syncytial Virus, CytomegalovirusView official trial listing → -
Completed NCT NCT05403307
A Real-world Evidence Study of BNT162b2 mRNA Covid-19 Vaccine Among Children in Brazil
Hospital Moinhos de Vento 757 participants Est. completion 2023-07-17 5 sitesOther conditions: COVID-19View official trial listing → -
Completed NCT NCT05406908
Intradermal Tozinameran for Patients With Immune-mediated Dermatologic Diseases
Not yet reported Mahidol University 109 participants Est. completion 2023-05-01 1 site Stand-aloneOther conditions: Bullous Dermatoses, Psoriasis, COVID-19 VaccinesView official trial listing → -
Status unknown NCT NCT05409300
Evaluation of the Immunogenicity and Safety BBIBP-CorV Vaccine for COVID-19 in Adults in Guinea
Not yet reported ANRS, Emerging Infectious Diseases 200 participants Est. completion 2025-02 2 sitesOther conditions: COVID-19, Vaccine Adverse Reaction, Sars-CoV-2 Infection, Healthy VolunteerView official trial listing → -
Completed NCT NCT05424952
The Effectiveness of Conversational AI Service (Chatbot) Utilization on Vaccine Confidence
Not yet reported The University of Hong Kong 1000 participants Est. completion 2023-02-17 3 sitesOther conditions: Vaccination HesitancyView official trial listing → -
Completed NCT NCT05433285
Immuno-bridging Study of COVID-19 Protein Subunit Recombinant Vaccine
Not yet reported PT Bio Farma 4050 participants Est. completion 2023-08-31 4 sitesOther conditions: COVID-19View official trial listing → -
Status unknown NCT NCT05434585
A Study to Evaluate Safety, Tolerability, and Immunogenicity of SARS-CoV-2 Variant (COVID-19) mRNA Vaccines
Not yet reported Suzhou Abogen Biosciences Co., Ltd. 60 participants Est. completion 2023-08-30 2 sitesOther conditions: COVID-19View official trial listing → -
Completed NCT NCT05435027
Study of Self-Amplifying Messenger Ribonucleic Acid (samRNA) Vaccines Against COVID-19 in Healthy Adults and People Living With Human Immunodeficiency Virus (HIV)
Not yet reported Gritstone bio, Inc. 342 participants Est. completion 2024-03-06 4 sitesOther conditions: COVID-19, SARS-CoV-2View official trial listing → -
Status unknown NCT NCT05439824
A Study of SARS-CoV-2 mRNA Vaccine (SYS6006) in Chinese Healthy Participants Aged 18 Years or More
Not yet reported CSPC ZhongQi Pharmaceutical Technology Co., Ltd. 450 participants Est. completion 2023-06-28 2 sitesOther conditions: SARS-CoV-2 InfectionView official trial listing → -
Withdrawn NCT NCT05442684
A Study to Evaluate the Safety and Immunogenicity of Ad5-vector Based Vaccine Against Coronavirus Variants in Adults (≥18 Years) Immunized With 2 Doses of mRNA Vaccines Plus One Dose of Booster AZD1222 Vaccine
Not yet reported CanSino Biologics Inc. Est. completion 2023-06-30 Stand-aloneOther conditions: COVID-19View official trial listing → -
Status unknown NCT NCT05453487
Immunogenicity and Safety of an Inactivated SARS-CoV-2 Vaccine (Sinopharm BBIBP-CorV) Coadministered With Rabies Vaccine
Not yet reported China National Biotec Group Company Limited 360 participants Est. completion 2023-06-30 2 sites Stand-aloneOther conditions: COVID-19, RabiesView official trial listing → -
Status unknown NCT NCT05455983
COVID-19 Vaccine and Development of Immune Thrombocytopenic Purpura
Assiut University 500 participants Est. completion 2023-12-01 1 siteOther conditions: COVID-19 VaccineView official trial listing → -
Completed NCT NCT05463354
Safety and Immunogenicity of Recombinant COVID-19 Vaccine (Sf9 Cell) as a Booster
Not yet reported WestVac Biopharma Co., Ltd. 410 participants Est. completion 2024-01-26 1 site Stand-aloneOther conditions: COVID-19, SARS-CoV-2 InfectionView official trial listing → -
Status unknown NCT NCT05468021
Puerto Rico COVID-19 Vaccine Uptake Study
Not yet reported University of Puerto Rico 394 participants Est. completion 2023-06 2 sites Stand-aloneOther conditions: COVID-19View official trial listing → -
Completed NCT NCT05470894
Liver Injury After COVID-19 Vaccination
Humanity & Health Medical Group Limited 379 participants Est. completion 2024-12-31 3 sitesOther conditions: Subjects After COVID-19 VaccinationView official trial listing → -
Status unknown NCT NCT05471635
Variables Influencing Anti-COVID-19 Vaccinations Around the World: an Analysis Conducted on Aggregated Data Sourced From Institutional Databases to Understand Whether and How Different Variables Could Affect the Vaccine Coverage (WORLDCOV: Worldwide Determinants of COVID-19 Vaccination)
Alberto Peano 205 participants Est. completion 2022-07-20 1 siteOther conditions: COVID-19 VaccinesView official trial listing → -
Status unknown NCT NCT05473936
A CHW Intervention to Identify and Decrease Barriers to COVID 19 Testing & Vaccination
Not yet reported Charles Drew University of Medicine and Science 66 participants Est. completion 2023-05 2 sitesOther conditions: Vaccine Hesitancy, COVID-19 Testing, Community Health WorkersView official trial listing → -
Completed NCT NCT05475704
Effectiveness of Chinese COVID-19 Vaccines in Latin America and the Caribbean
P95 59 participants Est. completion 2023-07-11 5 sitesOther conditions: COVID-19View official trial listing → -
Withdrawn NCT NCT05476822
Profiling Spike Protein Antibody Response Post COVID-19 Booster
David Grant U.S. Air Force Medical Center Est. completion 2023-06Other conditions: COVID-19 Booster, Spike Protein IgG AntibodyView official trial listing → -
Completed NCT NCT05477186
Safety and Immunogenicity Study of a Booster Dose of the Investigational CV0501 mRNA COVID-19 Vaccine in Adults at Least 18 Years Old
Not yet reported GlaxoSmithKline 185 participants Est. completion 2023-08-18 17 sitesOther conditions: COVID-19, SARS-CoV-2View official trial listing → -
Completed NCT NCT05481801
Adherence to Guidelines VAccination in Type 1 DIabetes Mellitus Patients (AVADI-2)
Castilla-La Mancha Health Service 300 participants Est. completion 2022-12-31 1 siteOther conditions: Type 1 DiabetesView official trial listing → -
Status unknown NCT NCT05490108
Evaluation of Safety and Immunogenicity of the Recombinant ZR202-CoV and ZR202a-CoV Vaccines in Adults.
Not yet reported, Not yet reported Shanghai Zerun Biotechnology Co.,Ltd 60 participants Est. completion 2023-08 1 siteOther conditions: SARS-CoV-2 Infection, COVID-19View official trial listing → -
Status unknown NCT NCT05492643
The Safety and Immunogenicity of SARS-CoV-2 mRNA Vaccine (SYS6006) as Heterologous Booster in Participants Aged 18 Years and Older Vaccinated With Inactivated SARS-CoV-2 Vaccine
Not yet reported Zhongnan Hospital 1000 participants Est. completion 2023-03-01 1 siteOther conditions: SARS-CoV-2, Safety, ImmunotoxicityView official trial listing → -
Status unknown NCT NCT05493917
A Real-world Study to Evaluate the Safety and Immunogenicity of a Third-dose Booster After Two Doses of an Inactivated COVID-19 Vaccine
Huashan Hospital 2000 participants Est. completion 2022-12-31 1 siteOther conditions: COVID-19, Vaccine ReactionView official trial listing → -
Completed NCT NCT05499299
Volatility and Heterogeneity of Vaccine Sentiments Means Continuous Monitoring is Needed When Measuring Message Effectiveness
Not yet reported The University of Hong Kong 127000 participants Est. completion 2022-04-01 1 siteOther conditions: Vaccine-Preventable Diseases, Vaccine RefusalView official trial listing → -
Completed NCT NCT05499351
A Study of Booster Immunization With COVID-19 Vaccine,Inactivated Co -Administration With Influenza Vaccine and Pneumococcal Polysaccharide Vaccine
Not yet reported Sinovac Biotech Co., Ltd 3000 participants Est. completion 2022-05-05 1 site Stand-aloneOther conditions: COVID-19View official trial listing → -
Active, not recruiting NCT NCT05507671
The Role of BCG Vaccine in the Clinical Evolution of COVID-19 and in the Efficacy of Anti-SARS-CoV-2 Vaccines
Not yet reported Oswaldo Cruz Foundation 556 participants Est. completion 2025-12-31 4 sitesOther conditions: COVID-19View official trial listing → -
Status unknown NCT NCT05508477
UNAIR Inactivated COVID-19 Vaccine Phase III (Immunobridging Study)
Not yet reported Dr. Soetomo General Hospital 4005 participants Est. completion 2023-05-28 5 sitesOther conditions: COVID-19 Pandemic, COVID-19 VaccinesView official trial listing → -
Status unknown NCT NCT05518760
COVID-19 Effectiveness Study in the Philippines
University of the Philippines 3000 participants Est. completion 2024-03-15 1 siteOther conditions: COVID-19, Vaccine Effectiveness Against COVID-19, Hospitalized COVID-19View official trial listing → -
Completed NCT NCT05525208
Booster Study of COVID-19 Protein Subunit Recombinant Vaccine
Not yet reported PT Bio Farma 696 participants Est. completion 2023-08-04 2 sites Stand-aloneOther conditions: COVID-19View official trial listing → -
Completed NCT NCT05531058
The Impact of a Web-based Psychoeducation Programme with a Motivational AI Chatbot on Covid-19 Vaccine Hesitancy
Not yet reported The Hong Kong Polytechnic University 168 participants Est. completion 2024-06-01 1 siteOther conditions: Vaccine Hesitancy, COVID-19View official trial listing → -
Status unknown NCT NCT05534035
Booster Superiority Study of PTX-COVID19-B Compared to Vaxzevria® in Adults Aged 18 Years and Older
Not yet reported Everest Medicines (Singapore) Pte. Ltd. 450 participants Est. completion 2023-10-18Other conditions: SARS-CoV-2 InfectionView official trial listing → -
Withdrawn NCT NCT05541393
Engaging Church Health Ministries to Decrease Coronavirus Disease-19 Vaccine Hesitancy in Underserved Populations
Not yet reported Pennington Biomedical Research Center Est. completion 2023-06-30 1 siteOther conditions: COVID-19View official trial listing → -
Completed NCT NCT05541861
Safety and Effects of an Investigational COVID-19 Vaccine as Booster in Healthy People
Not yet reported BioNTech SE 383 participants Est. completion 2024-11-22 17 sitesOther conditions: SARS-CoV-2 Infection, COVID-19View official trial listing → -
Completed NCT NCT05542862
Booster Study of SpikoGen COVID-19 Vaccine
Not yet reported Vaxine Pty Ltd 81 participants Est. completion 2025-09-16 1 site Stand-aloneOther conditions: COVID-19View official trial listing → -
Terminated NCT NCT05543642
The COVID-19 VaccinE Response and Co-Administration in Rheumatology Patients (COVER-CoAd)
Not yet reported Oregon Health and Science University 129 participants Est. completion 2026-08-14 7 sitesOther conditions: Rheumatic DiseasesView official trial listing → -
Completed NCT NCT05543993
COVID Booster in Pregnancy and Lactation
Thomas Jefferson University 150 participants Est. completion 2024-06-10 1 siteOther conditions: COVID-19View official trial listing → -
Completed NCT NCT05548439
Safety, Tolerability, and Immunogenicity of Trivalent Coronavirus Vaccine Candidate VBI-2901a
Not yet reported VBI Vaccines Inc. 103 participants Est. completion 2024-01-16 7 sitesOther conditions: COVID-19, Coronavirus InfectionsView official trial listing → -
Completed NCT NCT05567471
Phase 3 Study to Evaluate Immunogenicity and Safety of BBV154 Booster Dose
Not yet reported Bharat Biotech International Limited 875 participants Est. completion 2022-09-28 9 sitesOther conditions: COVID-19 Respiratory InfectionView official trial listing → -
Status unknown NCT NCT05568693
Sequential Enhanced Safety Study of a Novel Coronavirus Messenger RNA (mRNA) Vaccine in Adults Aged 18 Years and Older.
Not yet reported Yu Qin 800 participants Est. completion 2023-03-21 1 siteOther conditions: Corona Virus Disease 2019(COVID-19)View official trial listing → -
Completed NCT NCT05572879
A Phase III Study of COVID-19 Vaccine EuCorVac-19 in Healthy Adults
Not yet reported EuBiologics Co.,Ltd 2600 participants Est. completion 2024-02-09 1 site Stand-aloneOther conditions: COVID-19View official trial listing → -
Completed NCT NCT05584735
Determining the Relationship Between Gut Microbiota and Immune Response to Influenza or COVID-19 Vaccine
University of Wisconsin, Madison 46 participants Est. completion 2025-03-20 1 siteOther conditions: Inflammatory Bowel DiseasesView official trial listing → -
Status unknown NCT NCT05585567
A Preliminary Exploratory Study to Evaluate the Safety and Immunogenicity of Omicron Variant Bivalent Vaccine V-01-B5
Not yet reported Livzon Pharmaceutical Group Inc. 48 participants Est. completion 2023-09-11 1 siteOther conditions: COVID-19 PandemicView official trial listing → -
Withdrawn NCT NCT05587881
Clinical Study on the Impact of Covid-19 Vaccine on Allogeneic Hematopoietic Stem Cell Transplantation
The First Affiliated Hospital of Soochow University Est. completion 2023-11-01 1 siteOther conditions: Hematologic DiseasesView official trial listing → -
Completed NCT NCT05599555
Community-based Sero-epidemiological Study of COVID-19
The University of Hong Kong 9600 participants Est. completion 2023-03-31 1 siteOther conditions: COVID-19View official trial listing → -
Status unknown NCT NCT05602558
The Phase Ⅱ/Ⅲ Trial of LYB001
Not yet reported, Not yet reported Yantai Patronus Biotech Co., Ltd. 18000 participants Est. completion 2024-02Other conditions: COVID-19View official trial listing → -
Completed NCT NCT05603052
A Phase III of COVID-19 Vaccine EuCorVac-19 in Healthy Adults Aged 18 Years and Older
Not yet reported EuBiologics Co.,Ltd 2852 participants Est. completion 2024-01-15 1 site Stand-aloneOther conditions: COVID-19View official trial listing → -
Completed NCT NCT05604690
Safety and Efficacy of Intranasal Administration of Avacc 10 Vaccine Against COVID-19 in Healthy Volunteers
Not yet reported Intravacc B.V. 40 participants Est. completion 2024-01-15 1 siteOther conditions: COVID-19View official trial listing → -
Enrolling by invitation NCT NCT05610423
Covid-19 Vaccine Associated Myocarditis and Pericarditis in Norway
Oslo University Hospital 100 participants Est. completion 2032-12-31 1 siteOther conditions: MyocarditisView official trial listing → -
Withdrawn NCT NCT05614245
Safety, Tolerability, and Immunogenicity of Trivalent Coronavirus Vaccine Candidate VBI-2901e With E6020 Adjuvant
Not yet reported VBI Vaccines Inc. Est. completion 2024-06 4 sitesOther conditions: COVID-19, Coronavirus InfectionsView official trial listing → -
Status unknown NCT NCT05618548
Vaccination Against COVID-19 in Pregnant and Lactating Women in Belgium
Universiteit Antwerpen 110 participants Est. completion 2023-06-30 1 siteOther conditions: Covid19View official trial listing → -
Status unknown NCT NCT05630313
Gene Sequencing as a Strategy for Identifying Genetic Factors Associated With Serious Adverse Events After Covid-19 Vaccines in Use in Brazil
The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz) 100 participants Est. completion 2023-09-30 1 siteOther conditions: Vaccine-induced Thrombotic Thrombocytopenia Syndrome, Guillain-Barre Syndrome, Acute Disseminated Encephalomyelitis, Transverse MyelitisView official trial listing → -
Not yet recruiting NCT NCT05633446
Next Generation T-cell Vaccine Against Coronavirus Disease (COVID-19)
Not yet reported, Not yet reported Gylden Pharma Ltd 110 participants Est. completion 2026-12-01 2 sitesOther conditions: Coronavirus, SARS-CoV-2 Infection, COVID-19View official trial listing → -
Completed NCT NCT05652543
A PhaseⅡ Study to Evaluate the Safety & Immunogenicity of SARS-CoV-2 Alpha/Beta/Delta/Omicron Variants COVID-19 Vaccine
Not yet reported Sinocelltech Ltd. 518 participants Est. completion 2024-01-15 4 sites Stand-aloneOther conditions: COVID-19 PandemicView official trial listing → -
Completed NCT NCT05655351
Effect of a Vaccination Against COVID-19 on Monocyte Production of Oxygenated Derivatives.
Not yet reported Centre Hospitalier Universitaire de Nīmes 30 participants Est. completion 2024-07-30 1 siteOther conditions: CORONAVIRUS INFECTIONSView official trial listing → -
Status unknown NCT NCT05679466
An Investigator Initiated, Randomized, Double-blinded, Placebo-controlled Clinical Trial to Evaluate the Safety, Immunogenicity and Efficacy of the Recombinant Two-component COVID-19 Vaccine (CHO Cell) in Adults Aged 18 Years and Older
Not yet reported Yu Qin 3300 participants Est. completion 2023-12-31 1 siteOther conditions: Prevention of COVID-19 Caused by SARS-CoV-2View official trial listing → -
Status unknown NCT NCT05682638
A Global Multi-center Clinical Study of SARS-CoV-2 mRNA Vaccine for the Prevention of COVID-19
Not yet reported AIM Vaccine Co., Ltd. 34000 participants Est. completion 2025-12 1 siteOther conditions: SARS-CoV-2View official trial listing → -
Completed NCT NCT05697705
Effectiveness of the Oxford-AstraZeneca COVID-19 Vaccine as a 2nd Booster, the REFORCO-Brazil Study
AstraZeneca 188814085 participants Est. completion 2023-05-18 1 siteOther conditions: COVID-19View official trial listing → -
Completed NCT NCT05715944
Incidence of COVID-19 Following Vaccination in Botswana Against SARS CoV 2
Not yet reported Botswana Harvard AIDS Institute Partnership 10888 participants Est. completion 2022-12-30 1 siteOther conditions: COVID-19View official trial listing → -
Status unknown NCT NCT05745545
Clinical Trial of COVID-19 Vaccine(SARS-CoV-2 Variant(Omicron BA.5) mRNA Vaccine) in Participants Aged 18 Years and Over
Not yet reported AIM Vaccine Co., Ltd. 3200 participants Est. completion 2023-11 1 siteOther conditions: SARS-CoV-2View official trial listing → -
Status unknown NCT NCT05749926
Immunogenicity and Reactogenicity of the Beta-variant Recombinant Protein Booster Vaccine (VidPrevtyn Beta, Sanofi) Compared to a Bivalent mRNA Vaccine (Comirnaty Original/Omicron BA.4-5, BioNTech-Pfizer) in Adults Previously Vaccinated With at Least 3 Doses of COVID-19 mRNA Vaccine
Not yet reported Assistance Publique - Hôpitaux de Paris 248 participants Est. completion 2024-07-12 1 site Stand-aloneOther conditions: Vaccine Reaction, COVID-19View official trial listing → -
Completed NCT NCT05765578
An Observational Study of Moderna COVID-19 Bivalent Vaccines (Original and Omicron BA.4/BA.5) and 2023 Updated mRNA COVID-19 Vaccines (XBB.1.5)
ModernaTX, Inc. 1713 participants Est. completion 2024-06-17 1 siteOther conditions: COVID-19View official trial listing → -
Completed NCT NCT05770180
Phase II Clinical Trial of Recombinant COVID-19 Variant Vaccine (Sf9 Cell)
Not yet reported WestVac Biopharma Co., Ltd. 450 participants Est. completion 2024-04-09 1 siteOther conditions: COVID-19View official trial listing → -
Terminated NCT NCT05788185
Safety & Immunogenicity of RVM-V001/RVM-V002 or RVMV001+RVMV002 (Co Administered as Separate Injections) in Healthy Individuals
Not yet reported, Not yet reported RVAC Medicines (US), Inc. 24 participants Est. completion 2023-09-21 1 siteOther conditions: Infectious Disease, COVID-19View official trial listing → -
Completed NCT NCT05808348
Effects of COVID-19 on the Elderly
Kırklareli University 114 participants Est. completion 2023-05-11 1 siteOther conditions: Pain, Fear, Falling, Physical Activity, COVID-19, AgedView official trial listing → -
Status unknown NCT NCT05812586
Assessment of Immunogenicity, Safety and Reactogenicity of a Booster Dose of Various COVID-19 Vaccine Platforms in Individuals Primed With Several Regimes.
Not yet reported D'Or Institute for Research and Education 760 participants Est. completion 2023-09 2 sitesOther conditions: COVID-19View official trial listing → -
Completed NCT NCT05815498
A Study of mRNA-1283 Injection Compared With mRNA-1273 Injection in Participants ≥12 Years of Age to Prevent COVID-19
Not yet reported ModernaTX, Inc. 13553 participants Est. completion 2025-04-12 230 sitesOther conditions: COVID-19View official trial listing → -
Active, not recruiting NCT NCT05822219
Vaccine Hesitancy in Black/African Americans With Rheumatic Diseases
Not yet reported Northwestern University 60 participants Est. completion 2027-12-31 1 site Stand-aloneOther conditions: Rheumatic Diseases, COVID-19 Vaccine, COVID-19, SLEView official trial listing → -
Status unknown NCT NCT05831826
Effectiveness and Safety of the Inactivated COVID-19 Vaccine in Thousands of Patients With Autoimmune Diseases in China
Zhejiang Chinese Medical University 1200 participants Est. completion 2024-12 1 siteOther conditions: COVID-19 Vaccines, Autoimmune DiseasesView official trial listing → -
Status unknown NCT NCT05855408
Effectiveness of a Second COVID-19 Vaccine Booster in Chinese Adults
Not yet reported Jiangsu Province Centers for Disease Control and Prevention 10000 participants Est. completion 2024-12-31 1 siteOther conditions: COVID-19View official trial listing → -
Completed NCT NCT05863429
Observational National Vaccine Study
Health Institutes of Turkey 200 participants Est. completion 2024-04-01 8 sitesOther conditions: COVID-19 InfectionView official trial listing → -
Completed NCT NCT05866237
COVID-19 Vaccine Uptake Amongst Underserved Populations in East London
Not yet reported Queen Mary University of London 5903 participants Est. completion 2025-04-30 5 sitesOther conditions: COVID-19, Influenza, Vaccination RefusalView official trial listing → -
Status unknown NCT NCT05873374
Evaluation of Safety, Tolerability, Reactogenicity, Immunogenicity of Baiya SARS-CoV-2 Vax 2 as a Booster for COVID-19
Not yet reported Baiya Phytopharm Co., Ltd. 75 participants Est. completion 2024-08 1 siteOther conditions: COVID-19 Vaccine, COVID-19View official trial listing → -
Terminated NCT NCT05876377
Use and Effectiveness of COVID-19 Vaccines Using State Vaccine Registries and Insurance Claims Data
Pfizer 1 participants Est. completion 2026-05-31 1 siteOther conditions: SARS-CoV-2, COVID-19, Post-Acute COVID-19 SyndromeView official trial listing → -
Completed NCT NCT05894525
Post-Marketing Safety Study in Japan in Participants With High Risk of Severe Exacerbation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) mRNA-1273 COVID-19 Vaccine
ModernaTX, Inc. 8844 participants Est. completion 2023-05-26 1 siteOther conditions: SARS-CoV-2View official trial listing → -
Completed NCT NCT05894590
Post-Marketing Non-Acute Safety Study in Japan After Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) mRNA-1273 COVID-19 Vaccine in Persons at High Risk of Severe COVID-19
ModernaTX, Inc. 13680 participants Est. completion 2023-12-20 1 siteOther conditions: SARS-CoV-2View official trial listing → -
Completed NCT NCT05895110
To Evaluate the Immunogenicity and Safety of Sequential Booster Immunization of Recombinant Novel Coronavirus Vaccine (CHO Cells) for SARS-CoV-2
Not yet reported Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. 240 participants Est. completion 2022-11-19 1 siteOther conditions: COVID-19View official trial listing → -
Completed NCT NCT05907044
A Study to Investigate the Safety, Immunogenicity of Bivalent mRNA Vaccine RQ3027 and RQ3025 as a Booster Dose in Healthy Adults
Not yet reported Affiliated Hospital of Yunnan University 376 participants Est. completion 2023-11-23 1 siteOther conditions: COVID-19View official trial listing → -
Status unknown NCT NCT05911048
A Clinical Trial of Recombinant COVID-19 Bivalent (XBB+Prototype) Protein Vaccine (Sf9 Cell) in Booster Vaccination
Not yet reported WestVac Biopharma Co., Ltd. 3100 participants Est. completion 2025-12-30Other conditions: COVID-19View official trial listing → -
Status unknown NCT NCT05911087
A Phase II/III Study to Evaluate the Immunogenicity and Safety and Efficacy of SWIM816 Vaccines for SARS-CoV-2
Not yet reported, Not yet reported Stemirna Therapeutics 800 participants Est. completion 2024-02-01 Stand-aloneOther conditions: Immunogenicity, SafetyView official trial listing → -
Completed NCT NCT05919472
Effects of Oral Iron Supplementation on Vaccine Response in Iron Deficient Kenyan Women
Not yet reported Nicole Stoffel 180 participants Est. completion 2024-07-16 1 site Stand-aloneOther conditions: Iron Deficiency AnemiaView official trial listing → -
Completed NCT NCT05924685
PREPARE-iVAC Trial
Not yet reported University Medical Center Groningen 110 participants Est. completion 2024-02-27 7 sitesOther conditions: COVID-19 Vaccines, Varicella Zoster Vaccine, Vaccine Response, ImmunosuppressionView official trial listing → -
Withdrawn NCT NCT05926440
Immunogenicity and Safety Study of SCB-2023 Vaccine as a Booster in Adults
Not yet reported Clover Biopharmaceuticals AUS Pty Est. completion 2023-08-17 3 sitesOther conditions: COVID-19View official trial listing → -
Terminated NCT NCT05926544
COVID-19 Vaccine Hesitancy Counseling Intervention for Pharmacists
Not yet reported University of North Carolina, Chapel Hill 16 participants Est. completion 2024-06-20 1 siteOther conditions: COVID-19View official trial listing → -
Completed NCT NCT05933304
A Study of the Effectiveness of Moderna COVID-19 Vaccine
ModernaTX, Inc. 927004 participants Est. completion 2023-11-17 1 siteOther conditions: SARS-CoV-2, COVID-19View official trial listing → -
Status unknown NCT NCT05933512
A Study to Evaluate the Immunogenicity and Safety of A Recombinant Protein COVID-19 Vaccine as Booster Vaccines
Not yet reported Sinocelltech Ltd. 600 participants Est. completion 2024-11-10Other conditions: COVID-19, SARS-CoV-2 InfectionView official trial listing → -
Completed NCT NCT05938075
Study of VXCO-100, a SARS-CoV Candidate Vaccine, in Adults in the Republic of South Africa
Not yet reported Vaccine Company, Inc, a wholly owned subsidiary of Eli Lilly and Company 130 participants Est. completion 2024-07-25 2 sitesOther conditions: SARS-CoV, SARS-CoV-2View official trial listing → -
Status unknown NCT NCT05939596
A Phase I Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of SARS-CoV-2 Bivalent mRNA Vaccine (LVRNA021)
Not yet reported AIM Vaccine Co., Ltd. 60 participants Est. completion 2024-08-25 1 siteOther conditions: SARS-CoV-2View official trial listing → -
Status unknown NCT NCT05939648
A Phase II Clinical Trial to Evaluate the Immunogenicity and Safety of SARS-CoV-2 Bivalent mRNA Vaccine (LVRNA021)
Not yet reported AIM Vaccine Co., Ltd. 450 participants Est. completion 2024-12-30 1 siteOther conditions: SARS-CoV-2View official trial listing → -
Completed NCT NCT05970887
Immunogenicity and Safety of Concomitant Administration of Bivalent COVID-19 Vaccines With Influenza Vaccines
Not yet reported Catholic Kwandong University 154 participants Est. completion 2023-12-15 1 siteOther conditions: Immune Response, SafetyView official trial listing → -
Completed NCT NCT05975060
A Study to Evaluate the Safety and Immunogenicity of an (Omicron Subvariant) COVID-19 Vaccine Booster Dose in Previously Vaccinated Participants and Unvaccinated Participants.
Not yet reported, Not yet reported Novavax 660 participants Est. completion 2024-05-20 30 sitesOther conditions: COVID-19View official trial listing → -
Terminated NCT NCT05977127
Intradermal Administration of a COVID-19 mRNA Vaccine in Elderly
Not yet reported Radboud University Medical Center 48 participants Est. completion 2024-03-21 1 siteOther conditions: Vaccination; Infection, COVID-19View official trial listing → -
Completed NCT NCT06006858
Post Authorization Safety Study Moderna COVID-19 Primary Vaccine
PT Bio Farma 1284 participants Est. completion 2023-03-31 18 sitesOther conditions: COVID-19View official trial listing → -
Completed NCT NCT06020118
Comparative Immunogenicity of Concomitant vs Sequential mRNA COVID-19 and Influenza Vaccinations
Not yet reported Duke University 455 participants Est. completion 2024-05-17 8 sitesOther conditions: Influenza, COVID-19View official trial listing → -
Terminated NCT NCT06022224
A 2nd Generation E1/E2B/E3-Deleted Adenoviral COVID-19 Vaccine: The TCELL VACCINE TRIAL
Not yet reported, Not yet reported ImmunityBio, Inc. 35 participants Est. completion 2023-07-19 1 siteOther conditions: COVID-19View official trial listing → -
Completed NCT NCT06036134
Reducing COVID-19 Vaccine Hesitancy Among Hispanic Parents
Not yet reported Arizona State University 80 participants Est. completion 2025-08-31 1 site Stand-aloneOther conditions: Vaccine-Preventable Diseases, COVID-19 Pandemic, Health-Related Behavior, Health Knowledge, Attitudes, Practice, NarrationView official trial listing → -
Completed NCT NCT06065176
The Efficacy of the 2023-2024 Updated COVID-19 Vaccines Against COVID-19 Infection
Not yet reported Sarang K. Yoon, DO, MOH 1188 participants Est. completion 2024-09-09 1 siteOther conditions: COVID-19, Vaccine-Preventable Diseases, SARS CoV 2 Infection, Upper Respiratory Tract Infection, Upper Respiratory DiseaseView official trial listing → -
Status unknown NCT NCT06091410
Immunogenicity of Concomitant Administration of COVID-19 Vaccines With Influenza Vaccines
Not yet reported Catholic Kwandong University 62 participants Est. completion 2025-06-25 2 sites Stand-aloneOther conditions: COVID-19, Influenza, Vaccine Reaction, Contaminant InjectedView official trial listing → -
Status unknown NCT NCT06113744
A Phase 1 Study to Evaluate the Safety and Immunogenicity of COVID-19 Vaccine
Not yet reported CNBG-Virogin Biotech (Shanghai) Ltd. 164 participants Est. completion 2024-06 1 siteOther conditions: SARS-CoV-2 InfectionView official trial listing → -
Completed NCT NCT06116669
Effects of Oral Iron Supplementation Before vs at Time of Vaccination on Immune Response in Iron Deficient Kenyan Women
Not yet reported Swiss Federal Institute of Technology 215 participants Est. completion 2024-07-31 1 site Stand-aloneOther conditions: Iron Deficiency AnemiaView official trial listing → -
Terminated NCT NCT06156228
Multilevel Intervention of COVID-19 Vaccine Uptake Among Latinos
Not yet reported San Diego State University 238 participants Est. completion 2025-04-01 2 sitesOther conditions: Vaccine HesitancyView official trial listing → -
Completed NCT NCT06189040
Immunogenicity After COVID-19 Vaccines in Adapted Schedules
Not yet reported Universiteit Antwerpen 580 participants Est. completion 2022-07-08 4 sitesOther conditions: Coronavirus Disease 2019, COVID-19View official trial listing → -
Active, not recruiting NCT NCT06189053
A Study to Assess Long-term Outcomes of Myocarditis Following Administration of COVID-19 mRNA Vaccine (SPIKEVAX)
ModernaTX, Inc. 1500 participants Est. completion 2028-10-31 1 siteOther conditions: MyocarditisView official trial listing → -
Status unknown NCT NCT06259578
UNAIR Inactivated COVID-19 Vaccine as Homologue Booster (Immunobridging Study)
Not yet reported Dr. Soetomo General Hospital 400 participants Est. completion 2024-12-29 1 siteOther conditions: COVID-19 Pandemic, COVID-19 Vaccines, COVID-19 Virus DiseaseView official trial listing → -
Status unknown NCT NCT06272253
UNAIR Inactivated COVID-19 Vaccine INAVAC as Heterologue Booster (Immunobridging Study) in Adolescent Subjects
Not yet reported Dr. Soetomo General Hospital 250 participants Est. completion 2024-07-19 1 siteOther conditions: COVID-19 Pandemic, COVID-19 VaccinesView official trial listing → -
Completed NCT NCT06279871
Immunogenicity and Safety Study of Self-amplifying mRNA COVID-19 Vaccine Administered With Influenza Vaccines in Adults
Not yet reported Arcturus Therapeutics, Inc. 1514 participants Est. completion 2024-11-21 29 sites Stand-aloneOther conditions: COVID-19View official trial listing → -
Status unknown NCT NCT06300853
Understanding Adaptive Immune Response After COVID-19 Vaccination Boosters to Improve Vaccination Strategies in Vulnerable Groups.
Not yet reported IRCCS Sacro Cuore Don Calabria di Negrar 350 participants Est. completion 2025-11 1 siteOther conditions: COVID-19View official trial listing → -
Status unknown NCT NCT06303635
Safety of UFRJvac, Trivalent COVID-19 Vaccine
Azidus Brasil 156 participants Est. completion 2025-11-25Other conditions: Healthy PeopleView official trial listing → -
Active, not recruiting NCT NCT06333704
Post-marketing Surveillance (PMS) Use-Result Surveillance With SPIKEVAX BIVALENT, SPIKEVAX X Injection, SPIKEVAX JN Injection and SPIKEVAX IN PRE-FILLED SYRINGE
ModernaTX, Inc. 4207 participants Est. completion 2029-03-29 26 sitesOther conditions: SARS-CoV-2View official trial listing → -
Completed NCT NCT06352580
Covid-19 Pandemic and Pediatric Dentistry
Abant Izzet Baysal University 438 participants Est. completion 2022-06-30 1 siteOther conditions: COVID-19 PandemicView official trial listing → -
Completed NCT NCT06360744
A Phase IV Vaccine Study Under the National Cohort Study of Effectiveness and Safety of SARS-CoV-2 (COVID-19) Vaccines.
Not yet reported Jens D Lundgren, MD 25 participants Est. completion 2023-12-31 5 sitesOther conditions: SARS CoV 2 InfectionView official trial listing → -
Completed NCT NCT06369272
Study to Assess Maternal and Infant Outcomes Following Exposure to SPIKEVAX During Pregnancy
ModernaTX, Inc. 1192 participants Est. completion 2023-10-20 1 siteOther conditions: Maternal Outcomes, Infant Outcomes, PregnancyView official trial listing → -
Completed NCT NCT06381843
A Clinical Study to Evaluate the Safety and Immunogenicity of the Recombinant COVID-19 Vaccine (Sf9 Cell) as a Booster
Not yet reported WestVac Biopharma Co., Ltd. 120 participants Est. completion 2023-12-30 1 site Stand-aloneOther conditions: COVID-19, SARS-CoV-2 InfectionView official trial listing → -
Completed NCT NCT06409663
A Strain Change Study for SARS-CoV-2 rS Vaccines
Not yet reported Novavax 60 participants Est. completion 2025-04-17 2 sites Stand-aloneOther conditions: Severe Acute Respiratory Syndrome Coronavirus 2 InfectionView official trial listing → -
Completed NCT NCT06503900
Simultaneous mRNA COVID-19 and IIV Vaccination in Pregnancy Study
Not yet reported Duke University 98 participants Est. completion 2025-11-19 6 sites Stand-aloneOther conditions: Birth Outcomes, Safety, Adverse Event Following ImmunizationView official trial listing → -
Withdrawn NCT NCT06567457
Immunogenicity and Safety Study of Monovalent Omicron XBB.1.5 Vaccine as a Booster in Adults
Not yet reported Clover Biopharmaceuticals AUS Pty Est. completion 2024-10Other conditions: COVID-19View official trial listing → -
Completed NCT NCT06575114
COVID-19 Vaccination Willingness in Older Adults Based on Self-determination Theory
Not yet reported Jing-Shan Deng 264 participants Est. completion 2023-11-17 1 siteOther conditions: Old Age; Debility, Vaccine Hesitancy, Vaccine RefusalView official trial listing → -
Completed NCT NCT06603090
Text4Vax: Text Message Reminders for Pediatric COVID-19 and Influenza Vaccines 2024-25 Season
Not yet reported Columbia University 66147 participants Est. completion 2025-04-30 4 sites Stand-aloneOther conditions: Influenza, COVID-19, Vaccination HesitancyView official trial listing → -
Active, not recruiting NCT NCT06605625
Vaccine Responses in Cancer
Abramson Cancer Center at Penn Medicine 250 participants Est. completion 2028-10 1 siteOther conditions: Viral VaccinesView official trial listing → -
Completed NCT NCT06680375
A Study of an Investigational Flu Seasonal/SARS-CoV-2 Combination Vaccine in Adults
Not yet reported GlaxoSmithKline 106 participants Est. completion 2025-06-09 9 sitesOther conditions: COVID-19View official trial listing → -
Completed NCT NCT06695130
Study of a Combination Vaccine Comprised of Different Recombinant Spike Antigen Levels of a Matrix-M Adjuvanted Recombinant COVID-19 Vaccine and Recombinant Influenza Vaccine in Adult Participants 50 Years of Age and Older
Not yet reported, Not yet reported Sanofi 980 participants Est. completion 2026-04-03 12 sitesOther conditions: COVID-19 Immunization, Influenza ImmunizationView official trial listing → -
Completed NCT NCT06763887
Evaluation of Immunogenicity of COVID-19 Vaccine in Chinese Population
Xijing Hospital 100 participants Est. completion 2024-06-30 1 siteOther conditions: COVIDView official trial listing → -
Completed NCT NCT06821061
A Study to Learn About How the Flu and COVID-19 Vaccines Act in Healthy People
Not yet reported, Not yet reported BioNTech SE 2650 participants Est. completion 2025-12-17 31 sites Stand-aloneOther conditions: Influenza, COVID-19 (Coronavirus Disease 2019)View official trial listing → -
Completed NCT NCT06831786
Immunogenicity of COVID-19 Vaccine Co-administration With Influenza Vaccine in Healthy Volunteers
Not yet reported Prince of Songkla University 36 participants Est. completion 2024-05-31 1 siteOther conditions: COVID - 19View official trial listing → -
Active, not recruiting NCT NCT07051031
COVID-19 Reactogenicity
Not yet reported Marcel Curlin 1000 participants Est. completion 2026-06-14 1 siteOther conditions: COVID-19View official trial listing → -
Completed NCT NCT07089706
A Study to Evaluate the Immunogenicity and Safety of mRNA-1283 COVID-19 Variant-containing Formulations
Not yet reported ModernaTX, Inc. 832 participants Est. completion 2026-06-16 5 sitesOther conditions: COVID-19View official trial listing → -
Completed NCT NCT07095231
Safety, Reactogenicity, and Immunogenicity Trial of STX-S SARS-CoV-2 Vaccine in Adults
Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 60 participants Est. completion 2026-06-16 3 sitesOther conditions: COVID-19View official trial listing → -
Completed NCT NCT07134725
Safety and Immunogenicity of a Chimeric Recombinant Covid19 Vaccine SpiN-Tec MCTI UFMG
Not yet reported, Not yet reported Federal University of Minas Gerais 432 participants Est. completion 2025-05-07 1 siteOther conditions: COVID - 19View official trial listing → -
Completed NCT NCT07254442
Investigation of the Impact of Medications Used in COVID-19 Treatment and COVID-19 Vaccine on Hearing
Zonguldak Bulent Ecevit University 90 participants Est. completion 2022-03-01 1 siteOther conditions: Hearing, COVID - 19, OtotoxicityView official trial listing → -
Completed NCT NCT07300839
A Study to Learn About a COVID-19 Vaccine in Healthy Adults 50 Through 64 Years of Age
Not yet reported BioNTech SE 5240 participants Est. completion 2026-09-22 196 sitesOther conditions: COVID-19, SARS-COV-2 InfectionView official trial listing → -
Not yet recruiting NCT NCT07390968
Self-Amplifying mRNA COVID-19 Vaccine (LUNAR-COV19) Versus Comirnaty Vaccine in Adult Hematopoietic Cell Transplant Patients
Not yet reported Fred Hutchinson Cancer Center 56 participants Est. completion 2029-01-01 1 siteOther conditions: Hematopoietic and Lymphatic System NeoplasmView official trial listing → -
Completed NCT NCT07610512
Immunomodulatory Effect of Probiotics on the Immunogenicity of Anti-SARS-CoV-2 Vaccines
Not yet reported Grape King Bio Ltd. 138 participants Est. completion 2022-03-31 1 siteOther conditions: COVID-19, Immune ResponseView official trial listing → -
Completed NCT NCT07655180
Safety and Serum Virus Neutralizing Antibody Responses of VYD2311, a COVID-19 Vaccine, and Coadministered VYD2311 With a COVID-19 Vaccine
Not yet reported Invivyd, Inc. 210 participants Est. completion 2026-08-15 1 siteOther conditions: COVID-19View official trial listing → -
Not yet recruiting NCT NCT07703475
A Safety, Reactogenicity and Immunogenicity Trial of RVX-sCPD9 Booster Intranasal COVID-19 Vaccine
Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 80 participants Est. completion 2027-11-15 4 sitesOther conditions: COVID -19View official trial listing → -
Completed NCT NCT07758309
Online Games to Help Canadian and U.S. Adults Identify COVID-19 and Vaccine Misinformation: Three Sequential Randomized Studies
Not yet reported University of South Carolina 3637 participants Est. completion 2020-12-28 1 siteOther conditions: COVID-19, Vaccine Hesitancy, Health Misinformation, CommunicationView official trial listing → -
Active, not recruiting NCT NCT07798648
A Study of COVID-19 Vaccine(s) in Children and Adults
Not yet reported BioNTech SE 713 participants Est. completion 2027-04-12 15 sitesOther conditions: COVID-19 VaccinesView official trial listing → -
Not yet recruiting NCT NCT07871448
Flu COVID Vaccine Views
George Washington University 550 participants Est. completion 2028-04-01 2 sitesOther conditions: Influenza, COVID-19, Vaccination WillingnessView official trial listing →
Efficacy history
Not yet reported.
Safety
Not yet reported.
Sources
Related On The Pen coverage
No related coverage yet.
This drug may be investigational and not yet approved for any use. Whether someone can join a clinical trial is determined only by that trial's own study team — On The Pen does not determine eligibility. Information here can change; always confirm current details on the official ClinicalTrials.gov listing or with the sponsor.
